Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Adoptive transfer of effector CD8+ T cells derived from central memory cells establishes persistent T cell memory in primates
Carolina Berger, … , Carole Elliott, Stanley R. Riddell
Carolina Berger, … , Carole Elliott, Stanley R. Riddell
Published December 3, 2007
Citation Information: J Clin Invest. 2008;118(1):294-305. https://doi.org/10.1172/JCI32103.
View: Text | PDF
Research Article Immunology Article has an altmetric score of 40

Adoptive transfer of effector CD8+ T cells derived from central memory cells establishes persistent T cell memory in primates

  • Text
  • PDF
Abstract

The adoptive transfer of antigen-specific T cells that have been expanded ex vivo is being actively pursued to treat infections and malignancy in humans. The T cell populations that are available for adoptive immunotherapy include both effector memory and central memory cells, and these differ in phenotype, function, and homing. The efficacy of adoptive immunotherapy requires that transferred T cells persist in vivo, but identifying T cells that can reproducibly survive in vivo after they have been numerically expanded by in vitro culture has proven difficult. Here we show that in macaques, antigen-specific CD8+ T cell clones derived from central memory T cells, but not effector memory T cells, persisted long-term in vivo, reacquired phenotypic and functional properties of memory T cells, and occupied memory T cell niches. These results demonstrate that clonally derived CD8+ T cells isolated from central memory T cells are distinct from those derived from effector memory T cells and retain an intrinsic capacity that enables them to survive after adoptive transfer and revert to the memory cell pool. These results could have significant implications for the selection of T cells to expand or to engineer for adoptive immunotherapy of human infections or malignancy.

Authors

Carolina Berger, Michael C. Jensen, Peter M. Lansdorp, Mike Gough, Carole Elliott, Stanley R. Riddell

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 Total
Citations: 9 19 21 28 29 37 25 29 27 35 27 34 35 37 28 36 30 10 496
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (496)

Title and authors Publication Year
TCR usage and epitope specificity amongst CD8+ and CD4+ SARS-CoV-2-specific T cells
Ulrik Fahnøe, Shan Feng, Alexander Underwood, Kivin Jacobsen, Amir Ameri, Thomas Blicher, Christina Sølund, Brad Rosenberg, Nina Weis, Liselotte Brix, Jens Bukh
Frontiers in immunology 2025
Enabling next-generation engineered TCR-T therapies based on high-throughput TCR discovery from diagnostic tumor biopsies
Kuilman T, Schrikkema DS, Gadiot J, Gomez-Eerland R, Bies L, Walker J, Spaapen RM, Kok H, Houg D, Viyacheva M, Claassen YB, Saornil M, Krijgsman O, Stringer B, Ding H, Geleijnse A, Meinema AC, Weissbrich B, Lancee M, Engele CG, Sabatino M, Chen PL, Tsai KY, Mulé JJ, Sondak VK, van den Bulk J, de Miranda NF, Jedema I, Haanen JG, van Heijst JW, Schumacher TN, Linnemann C, Bendle GM
Nature Communications 2025
LLT1 overexpression renders allogeneic-NK resistance and facilitates the generation of enhanced universal CAR-T cells
Zhu S, Zuo S, Li C, You X, Jiang E, Feng X, Luo Y
Journal of Experimental & Clinical Cancer Research : CR 2025
A multi-kinase inhibitor screen identifies inhibitors preserving stem-cell-like chimeric antigen receptor T cells
Song F, Tsahouridis O, Stucchi S, Walhart T, Mendell S, Hardy PB, Axtman M, Guduru SK, Gilbert TS, Graves LM, Herring LE, Savoldo B, Ma X, Woodcock M, Milner JJ, Ivanova A, Pearce KH, Xu Y, Dotti G
Nature Immunology 2025
Vaccine-induced T cell receptor T cell therapy targeting a glioblastoma stemness antigen
Chih YC, Dietsch AC, Koopmann P, Ma X, Agardy DA, Zhao B, De Roia A, Kourtesakis A, Kilian M, Krämer C, Suwala AK, Stenzinger M, Boenig H, Blum A, Pienkowski VM, Aman K, Becker JP, Feldmann H, Bunse T, Harbottle R, Riemer AB, Liu HK, Etminan N, Sahm F, Ratliff M, Wick W, Platten M, Green EW, Bunse L
Nature Communications 2025
Adoptive T Cell Therapy Targeting MAGE-A4
Chandora K, Chandora A, Saeed A, Cavalcante L
Cancers 2025
Tumor-specific CD8+ T cells from the bone marrow resist exhaustion and exhibit increased persistence in tumor-bearing hosts as compared with tumor-infiltrating lymphocytes
Zawidzka EM, Biavati L, Thomas A, Zanettini C, Marchionni L, Leone R, Borrello I
Journal for Immunotherapy of Cancer 2025
Adaptive immune responses against common viruses are sustained and functional in end-of-life patients
Olofsson A, Humbert M, Rekha RS, Frankling MH, Lund-Johansen F, Bergman P, Björkhem-Bergman L, Karlsson AC
iScience 2025
Safety, efficacy and total cost of point-of-care manufactured anti-CD19 CAR-T cell therapy in India: VELCART trial
Palani HK, Arunachalam AK, Kulkarni U, Yasar M, Venkatraman A, Palanikumar S, Radhakrishnan RN, Solomon M, Rajasekaran A, Bankar A, Datari PV, Selvarajan S, Korula A, Dash P, Schneider D, Wirthlin L, Abraham A, George B, Mathews V
Molecular Therapy Oncology 2025
Adoptive cell transfer therapy with ex vivo primed peripheral lymphocytes in combination with anti-PDL1 therapy effectively inhibits triple-negative breast cancer growth and metastasis
Gammelgaard OL, Terp MG, Kirkin AF, Johansen S, Traynor S, Vever H, Guldberg P, Kodahl AR, Gjerstorff MF, Ditzel HJ
Molecular Cancer 2024
CAR-T cell manufacturing: Major process parameters and next-generation strategies.
Ayala Ceja M, Khericha M, Harris CM, Puig-Saus C, Chen YY
Journal of Experimental Medicine 2024
"Digital twins elucidate critical role of T(scm) in clinical persistence of TCR-engineered cell therapy".
Joslyn LR, Huang W, Miles D, Hosseini I, Ramanujan S
npj Systems Biology and Applications 2024
Tipping the balance in autoimmunity: are regulatory t cells the cause, the cure, or both?
Hardtke-Wolenski M, Landwehr-Kenzel S
Molecular and Cellular Pediatrics 2024
Automated manufacture of ΔNPM1 TCR-engineered T cells for AML therapy
Yonezawa Ogusuku IE, Herbel V, Lennartz S, Brandes C, Argiro E, Fabian C, Hauck C, Hoogstraten C, Veld S, Hageman L, Teppert K, Koutsoumpli G, Griffioen M, Mockel-Tenbrinck N, Schaser T, de Groot R, Johnston IC, Lock D
2024
Exploring the evolution of T cell function and diversity across different stages of non-small cell lung cancer
Chang CY, Chang SC, Wei YF, Tseng YT, Chou CH, Chen YY, Chen CY, Ye YL
American journal of cancer research 2024
PD-1 downregulation enhances CAR-T cell antitumor efficiency by preserving a cell memory phenotype and reducing exhaustion.
Ouyang W, Jin SW, Xu N, Liu WY, Zhao H, Zhang L, Kang L, Tao Y, Liu Y, Wang Y, Wang J, Liu F, Yu L, Liu Z, Mi JQ
Journal for ImmunoTherapy of Cancer 2024
Peripheral T Cell Subpopulations as a Potential Surrogate Biomarker during Atezolizumab plus Bevacizumab Treatment for Hepatocellular Carcinoma.
Shirane Y, Fujii Y, Ono A, Nakahara H, Hayes CN, Miura R, Murakami S, Sakamoto N, Uchikawa S, Fujino H, Nakahara T, Murakami E, Yamauchi M, Miki D, Kawaoka T, Arihiro K, Tsuge M, Oka S
Cancers 2024
Novel and multiple targets for chimeric antigen receptor-based therapies in lymphoma.
Pang Y, Ghosh N
Frontiers in Oncology 2024
Higher TIGIT+ γδ T(CM) cells may predict poor prognosis in younger adult patients with non-acute promyelocytic AML.
Hou Q, Wang P, Kong X, Chen J, Yao C, Luo X, Li Y, Jin Z, Wu X
Frontiers in immunology 2024
The Confounding Role of Graft-Versus-Host Disease in Animal Models of Cancer Immunotherapy: A Systematic Review.
Ashraf H, Heydarnejad M, Kosari F
Archives of Iranian medicine 2024
EBV T-cell immunotherapy generated by peptide selection has enhanced effector functionality compared to LCL stimulation
Cooper RS, Sutherland C, Smith LM, Cowan G, Barnett M, Mitchell D, McLean C, Imlach S, Hayes A, Zahra S, Manchanayake C, Vickers MA, Graham G, McGowan NW, Turner ML, Campbell JD, Fraser AR
Frontiers in immunology 2024
Influencing factors and solution strategies of chimeric antigen receptor T-cell therapy (CAR–T) cell immunotherapy
WANG Z, ZHOU L, WU X
Oncology Research 2024
Targeting the membrane-proximal C2-set domain of CD33 for improved CAR T cell therapy
Fiorenza S, Lim SY, Laszlo GS, Kimble EL, Phi TD, Lunn-Halbert MC, Kirchmeier DR, Huo J, Kiem HP, Turtle CJ, Walter RB
Molecular Therapy Oncology 2024
HA-1–targeted T-cell receptor T-cell therapy for recurrent leukemia after hematopoietic stem cell transplantation
Krakow EF, Brault M, Summers C, Cunningham TM, Biernacki MA, Black RG, Woodward KB, Vartanian N, Kanaan SB, Yeh AC, Dossa RG, Bar M, Cassaday RD, Dahlberg A, Till BG, Denker AE, Yeung CC, Gooley TA, Maloney DG, Riddell SR, Greenberg PD, Chapuis AG, Newell EW, Furlan SN, Bleakley M
Blood 2024
Genetically modified and unmodified cellular approaches to enhance graft versus leukemia effect, without increasing graft versus host disease: the use of allogeneic cytokine-induced killer cells
Rambaldi B, Rizzuto G, Rambaldi A, Introna M
Frontiers in Immunology 2024
Choice of activation protocol impacts the yield and quality of CAR T cell product, particularly with older individuals
Mehta PH, Trollope GS, Leung P, Chinni SS, Iasinskaia A, Harrison AJ, Hughes\u2010Parry H, Jenkins MR, Kershaw MH, Jaworowski A, Slaney CY, Koldej RM, Ritchie DS, Quinn KM
Clinical & Translational Immunology 2024
Rapidly Manufactured CAR-T with Conserved Cell Stemness and Distinctive Cytokine-Secreting Profile Shows Improved Anti-Tumor Efficacy
Tsao ST, Gu M, Xiong Q, Deng Y, Deng T, Fu C, Zhao Z, Zhang H, Liu C, Zhong X, Xiang F, Huang F, Wang H
Vaccines 2024
Acute Myeloid Leukemia Skews Therapeutic WT1-specific CD8 TCR-T Cells Towards an NK-like Phenotype that Compromises Function and Persistence
Mazziotta F, Martin LE, Eagan DN, Bar M, Kinsella S, Paulson KG, Voillet V, Lahman MC, Hunter D, Schmitt TM, Duerkopp N, Yeung C, Tang TH, Gottardo R, Asano Y, Wilcox EC, Lee B, Zhang T, Lopedote P, Penter L, Wu CJ, Milano F, Greenberg PD, Chapuis AG
medRxiv 2024
Analysis of causes for poor persistence of CAR-T cell therapy in vivo
Kong Y, Tang L, You Y, Li Q, Zhu X
Frontiers in immunology 2023
Tuned activation of MSLN-CAR T cells induces superior antitumor responses in ovarian cancer models
Schoutrop E, Poiret T, El-Serafi I, Zhao Y, He R, Moter A, Henriksson J, Hassan M, Magalhaes I, Mattsson J
Journal for ImmunoTherapy of Cancer 2023
Comparative Pre-Clinical Analysis of CD20-Specific CAR T Cells Encompassing 1F5-, Leu16-, and 2F2-Based Antigen-Recognition Moieties
Belovezhets T, Kulemzin S, Volkova O, Najakshin A, Taranin A, Gorchakov A
International journal of molecular sciences 2023
Deconvolution of clinical variance in CAR-T cell pharmacology and response.
Kirouac DC, Zmurchok C, Deyati A, Sicherman J, Bond C, Zandstra PW
Nature Biotechnology 2023
CD19/CD20 Bispecific Chimeric Antigen Receptor (CAR) in Naïve/Memory T Cells for the Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma
Larson SM, Walthers CM, Ji B, Ghafouri SN, Naparstek J, Trent J, Chen JM, Roshandell M, Harris C, Khericha M, Schweppe T, Berent-Maoz B, Gosliner SB, Almaktari A, Ceja MA, Allen-Auerbach MS, Said J, Nawaly K, Mead M, de Vos S, Young PA, Oliai C, Schiller GJ, Timmerman JM, Ribas A, Chen YY
Cancer Discovery 2023
Targeting advanced prostate cancer with STEAP1 chimeric antigen receptor T cell and tumor-localized IL-12 immunotherapy.
Bhatia V, Kamat NV, Pariva TE, Wu LT, Tsao A, Sasaki K, Sun H, Javier G, Nutt S, Coleman I, Hitchcock L, Zhang A, Rudoy D, Gulati R, Patel RA, Roudier MP, True LD, Srivastava S, Morrissey CM, Haffner MC, Nelson PS, Priceman SJ, Ishihara J, Lee JK
Nature Communications 2023
Antitumor effect of CAR-T cells targeting transmembrane tumor necrosis factor alpha combined with PD-1 mAb on breast cancers
Ba H, Dai Z, Zhang Z, Zhang P, Yin B, Wang J, Li Z, Zhou X
Journal for ImmunoTherapy of Cancer 2023
Stepwise activities of mSWI/SNF family chromatin remodeling complexes direct T cell activation and exhaustion
Battistello E, Hixon KA, Comstock DE, Collings CK, Chen X, Hernaez JR, Lee S, Cervantes KS, Hinkley MM, Ntatsoulis K, Cesarano A, Hockemeyer K, Haining WN, Witkowski MT, Qi J, Tsirigos A, Perna F, Aifantis I, Kadoch C
Molecular Cell 2023
T cell immunotherapy for cervical cancer: challenges and opportunities
Yu L, Lanqing G, Huang Z, Xin X, Minglin L, Fa-hui L, Zou H, Min J
Frontiers in immunology 2023
Elderly CD8+ T cells in the focus for immunotherapeutic approaches
Lis A, Zöphel D
Aging 2023
A Potential Biomarker of Dynamic Change in Peripheral CD45RA−CD27+CD127+ Central Memory T Cells for Anti-PD-1 Therapy in Patients with Esophageal Squamous Cell Carcinoma
Sakuma M, Mimura K, Nakajima S, Kaneta A, Kikuchi T, Nirei A, Tada T, Hanayama H, Okayama H, Sakamoto W, Saito M, Momma T, Saze Z, Kono K
Cancers 2023
Single-cell transcriptomic profiling reveals immune cell heterogeneity in acute myeloid leukaemia peripheral blood mononuclear cells after chemotherapy.
Hu X, Cao D, Zhou Z, Wang Z, Zeng J, Hong WX
Cellular oncology (Dordrecht) 2023
Memory T Cells in the Immunoprevention of Cancer: A Switch from Therapeutic to Prophylactic Approaches.
Mittra S, Harding SM, Kaech SM
Journal of immunology (Baltimore, Md. : 1950) 2023
Tumor-Specific CD8+ T Cells from the Bone Marrow Resist Exhaustion and Exhibit Increased Persistence in Tumor-Bearing Hosts as Compared to Tumor Infiltrating Lymphocytes
Zawidzka EM, Biavati L, Thomas A, Zanettini C, Marchionni L, Leone R, Borrello I
2023
T cell memory revisited using single telomere length analysis
Roger L, Miners KL, Leonard L, Grimstead JW, Price DA, Baird DM, Ladell K
Frontiers in immunology 2023
Cell Granularity Reflects Immune Cell Function and Enables Selection of Lymphocytes with Superior Attributes for Immunotherapy
Wu T, Tan JH, Sin W, Luah YH, Tan SY, Goh M, Birnbaum ME, Chen Q, Cheow LF
Advanced Science 2023
Favorable Activity and Safety Profile of Memory-Enriched CD19-Targeted Chimeric Antigen Receptor T Cell Therapy in Adults with high-risk Relapsed/Refractory ALL
Aldoss I, Khaled SK, Wang X, Palmer J, Wang Y, Wagner JR, Clark MC, Simpson J, Paul J, Vyas V, Chien SH, Stein A, Pullarkat V, Salhotra A, Al Malki MM, Aribi A, Sandhu K, Thomas SH, Budde LE, Marcucci G, Brown CE, Forman SJ
Clinical cancer research 2023
CD276-CAR T cells and Dual-CAR T cells targeting CD276/FGFR4 promote rhabdomyosarcoma clearance in orthotopic mouse models
Timpanaro A, Piccand C, Dzhumashev D, Anton-Joseph S, Robbi A, Moser J, Rössler J, Bernasconi M
Journal of experimental & clinical cancer research : CR 2023
Insights gained from single-cell analysis of chimeric antigen receptor T-cell immunotherapy in cancer
Tang L, Huang ZP, Mei H, Hu Y
Military Medical Research 2023
Tracking Peripheral Memory T Cell Subsets in Advanced Nonsmall Cell Lung Cancer Treated with Hypofractionated Radiotherapy and PD-1 Blockade
Kang P, Yu H, Li Y, Wen X, Ye H, Luo Y, Yang Y, Yuan Q, Lin S
Journal of Oncology 2023
INSPIRED Symposium Part 4B: Chimeric Antigen Receptor T Cell Correlative Studies-Established Findings and Future Priorities.
Ligon JA, Ramakrishna S, Ceppi F, Calkoen FGJ, Diorio C, Davis KL, Jacoby E, Gottschalk S, Schultz LM, Capitini CM
Transplantation and cellular therapy 2023
Antigen-Specific TCR-T Cells for Acute Myeloid Leukemia: State of the Art and Challenges
S Kang, Y Li, J Qiao, X Meng, Z He, X Gao, L Yu
Frontiers in Oncology 2022
The ER-Mitochondria Interface as a Dynamic Hub for T Cell Efficacy in Solid Tumors
E Hunt, A Andrews, S Larsen, J Thaxton
Frontiers in Cell and Developmental Biology 2022
Role of Suprabasin in the Dedifferentiation of Follicular Epithelial Cell-Derived Thyroid Cancer and Identification of Related Immune Markers
H Tan, L Wang, Z Liu
Frontiers in Genetics 2022
Rapid manufacturing of non-activated potent CAR T cells
S Ghassemi, J Durgin, S Nunez-Cruz, J Patel, J Leferovich, M Pinzone, F Shen, K Cummins, G Plesa, V Cantu, S Reddy, F Bushman, S Gill, U ODoherty, R OConnor, M Milone
Nature Biomedical Engineering 2022
Enhancing CAR T function with the engineered secretion of C. perfringens neuraminidase
J Durgin, R Thokala, L Johnson, E Song, J Leferovich, V Bhoj, S Ghassemi, M Milone, Z Binder, D O'Rourke, R O'Connor
Molecular Therapy 2022
Allogeneic Chimeric Antigen Receptor Therapy in Lymphoma
A Khurana, Y Lin
Current Treatment Options in Oncology 2022
Novel CD19 chimeric antigen receptor T cells manufactured next-day for acute lymphoblastic leukemia
Zhang C, He J, Liu L, Wang J, Wang S, Liu L, Ge J, Gao L, Gao L, Kong P, Liu Y, Liu J, Han Y, Zhang Y, Sun Z, Ye X, Yin W, Sersch M, Shen L, Cao WW, Zhang X
Blood Cancer Journal 2022
Peptide vaccination activating Galectin-3-specific T cells offers a novel means to target Galectin-3-expressing cells in the tumor microenvironment.
Bendtsen SK, Perez-Penco M, Hübbe ML, Martinenaite E, Orebo Holmström M, Weis-Banke SE, Grønne Dahlager Jørgensen N, Jørgensen MA, Munir Ahmad S, Jensen KM, Friese C, Lundsager MT, Johansen AZ, Carretta M, Ødum N, Met Ö, Svane IM, Madsen DH, Andersen MH
OncoImmunology 2022
Monitoring of Circulating CAR T Cells: Validation of a Flow Cytometric Assay, Cellular Kinetics, and Phenotype Analysis Following Tisagenlecleucel.
Peinelt A, Bremm M, Kreyenberg H, Cappel C, Banisharif-Dehkordi J, Erben S, Rettinger E, Jarisch A, Meisel R, Schlegel PG, Beck O, Bug G, Klusmann JH, Klingebiel T, Huenecke S, Bader P
Frontiers in immunology 2022
The Impact of Esophageal Oncological Surgery on Perioperative Immune Function; Implications for Adjuvant Immune Checkpoint Inhibition
Donlon NE, Davern M, Sheppard AD, O\u2019Connell F, Dunne MR, Hayes C, Mylod E, Ramjit S, Temperley H, Mac Lean M, Cotter G, Bhardwaj A, Butler C, Conroy MJ, O\u2019Sullivan J, Ravi N, Donohoe CL, Reynolds JV, Lysaght J
Frontiers in immunology 2022
Impact of Manufacturing Procedures on CAR T Cell Functionality
Watanabe N, Mo F, McKenna MK
Frontiers in immunology 2022
Transcriptomic analysis reveals optimal cytokine combinations for SARS-CoV-2-specific T cell therapy products
Durkee-Shock J, Lazarski CA, Jensen-Wachspress MA, Zhang A, Son A, Kankate VV, Field NE, Webber K, Lang H, Conway SR, Hanley PJ, Bollard CM, Keller MD, Schwartz DM
2022
CAR T-Cell Therapy Predictive Response Markers in Diffuse Large B-Cell Lymphoma and Therapeutic Options After CART19 Failure
Caballero AC, Escribà-Garcia L, Alvarez-Fernández C, Briones J
Frontiers in immunology 2022
Hypoxia-inducible lentiviral gene expression in engineered human macrophages.
Chinn HK, Gardell JL, Matsumoto LR, Labadie KP, Mihailovic TN, Lieberman NAP, Davis A, Pillarisetty VG, Crane CA
Journal for ImmunoTherapy of Cancer 2022
High CAR intensity of expression confers enhanced antitumor effect against lymphoma without functional exhaustion.
Caballero AC, Escribà-Garcia L, Pujol-Fernández P, Escudero-López E, Ujaldón-Miró C, Montserrat-Torres R, Sierra J, Alvarez-Fernández C, Briones J
Cancer Gene Therapy 2022
Biomarker correlates with response to NY-ESO-1 TCR T cells in patients with synovial sarcoma.
Gyurdieva A, Zajic S, Chang YF, Houseman EA, Zhong S, Kim J, Nathenson M, Faitg T, Woessner M, Turner DC, Hasan AN, Glod J, Kaplan RN, D'Angelo SP, Araujo DM, Chow WA, Druta M, Demetri GD, Van Tine BA, Grupp SA, Fine GD, Eleftheriadou I
Nature Communications 2022
Applying a clinical lens to animal models of CAR-T cell therapies
Duncan BB, Dunbar CE, Ishii K
2022
Generation and Functional Characterization of PLAP CAR-T Cells against Cervical Cancer Cells
Yekehfallah V, Pahlavanneshan S, Sayadmanesh A, Momtahan Z, Ma B, Basiri M
Biomolecules 2022
Treatment of aggressive T-cell lymphoma/leukemia with anti-CD4 CAR T cells.
Feng J, Xu H, Cinquina A, Wu Z, Zhang W, Sun L, Chen Q, Tian L, Song L, Pinz KG, Wada M, Jiang X, Hanes WM, Ma Y, Zhang H
Frontiers in immunology 2022
Chimeric antigen receptor engineered T cells and their application in the immunotherapy of solid tumours.
Mao R, Hussein MS, He Y
Expert Reviews in Molecular Medicine 2022
Decentralized manufacturing of anti CD19 CAR-T cells using CliniMACS Prodigy®: real-world experience and cost analysis in India.
Palani HK, Arunachalam AK, Yasar M, Venkatraman A, Kulkarni U, Lionel SA, Selvarajan S, Korula A, Abraham A, George B, Adair JE, Orentas R, Dropulic B, Mathews V
Bone Marrow Transplantation 2022
Expression profile and prognostic values of LSM family in skin cutaneous melanoma.
Sun X, Zhang J, Xiao C, Ge Z
BMC Medical Genomics 2022
Expression of TRX1 optimizes the antitumor functions of human CAR T cells and confers resistance to a pro-oxidative tumor microenvironment
Balta E, Janzen N, Kirchgessner H, Toufaki V, Orlik C, Liang J, Lairikyengbam D, Abken H, Niesler B, Müller-Decker K, Ruppert T, Samstag Y
Frontiers in immunology 2022
Manipulating T-cell metabolism to enhance immunotherapy in solid tumor
Chen C, Wang Z, Ding Y, Qin Y
Frontiers in immunology 2022
AIM™ platform: A new immunotherapy approach for viral diseases.
Langan D, Wang R, Tidwell K, Mitiku S, Farrell A, Johnson C, Parks A, Suarez L, Jain S, Kim S, Jones K, Oelke M, Zeldis J
Frontiers in Medicine 2022
Delineation of T cell subsets in chronic rhinosinusitis with nasal polyps
Zahran AM, El-Badaway O, Elsayh IK, Osman MM
Acta Otorhinolaryngologica Italica 2022
Cellular Cancer Immunotherapy Development and Manufacturing in the Clinic
Fenton GA, Mitchell DA
Clinical cancer research 2022
Development of a cGMP-compliant process to manufacture donor-derived, CD45RA-depleted memory CD19-CAR T cells.
Kim-Hoehamer YI, Riberdy JM, Zheng F, Park JJ, Shang N, Métais JY, Lockey T, Willis C, Akel S, Moore J, Meagher MM, Velasquez MP, Triplett BM, Talleur AC, Gottschalk S, Zhou S
Gene Therapy 2022
Expansion of donor-unrestricted MAIT cells with enhanced cytolytic function suitable for TCR-redirection
Tiphaine Parrot, Katie Healy, Caroline Boulouis, Michał J. Sobkowiak, Edwin Leeansyah, Soo Aleman, Antonio Bertoletti, Margaret Sällberg Chen, Johan K. Sandberg
JCI Insight 2021
Immune inactivation of anti-simian immunodeficiency virus chimeric antigen receptor T cells in rhesus macaques
F Haeseleer, Y Fukazawa, H Park, B Varco-Merth, BJ Rust, JV Smedley, K Eichholz, CW Peterson, R Mason, HP Kiem, M Roederer, LJ Picker, AA Okoye, L Corey
Molecular Therapy — Methods & Clinical Development 2021
Protective T cell receptor identification for orthotopic reprogramming of immunity in refractory virus infections
TA Stief, T Kaeuferle, TR Müller, M Döring, LM Jablonowski, K Schober, J Feucht, KM Dennehy, S Willier, F Blaeschke, R Handgretinger, P Lang, DH Busch, T Feuchtinger
Molecular Therapy 2021
Metabolic barriers to cancer immunotherapy
K DePeaux, GM Delgoffe
Nature Reviews Immunology 2021
Improving CAR T-Cell Persistence
V Pietrobon, LA Todd, A Goswami, O Stefanson, Z Yang, F Marincola
International journal of molecular sciences 2021
A Correlation Between Differentiation Phenotypes of Infused T Cells and Anti-Cancer Immunotherapy
H Ren, K Cao, M Wang
Frontiers in immunology 2021
Early memory differentiation and cell death resistance in T cells predicts melanoma response to sequential anti-CTLA4 and anti-PD1 immunotherapy
I Vanmeerbeek, DM Borras, J Sprooten, O Bechter, S Tejpar, AD Garg
Genes and Immunity 2021
Ectopic activation of the miR-200c–EpCAM axis enhances antitumor T cell responses in models of adoptive cell therapy
M Zhang, Z Zhao, Y Pritykin, M Hannum, AC Scott, F Kuo, V Sanghvi, TA Chan, V Seshan, HG Wendel, A Schietinger, M Sadelain, M Huse
Science Translational Medicine 2021
CAR T cells: Building on the CD19 paradigm
AG Levin, I Rivière, Z Eshhar, M Sadelain
European Journal of Immunology 2021
The Promise of Personalized TCR-Based Cellular Immunotherapy for Cancer Patients
M Arnaud, S Bobisse, J Chiffelle, A Harari
Frontiers in immunology 2021
HIV-1-Specific CAR-T Cells With Cell-Intrinsic PD-1 Checkpoint Blockade Enhance Anti-HIV Efficacy in vivo
Z Jiang, H Liang, H Pan, Y Liang, H Wang, X Yang, P Lu, X Zhang, J Yang, D Zhang, X Shen, J Wang, Z Liang, Q Lin, Y Wang, L Zhao, Y Zhong, H Lu, H Zhu
Frontiers in microbiology 2021
CAR T cell therapy as a promising approach in cancer immunotherapy: challenges and opportunities
M Akhoundi, M Mohammadi, SS Sahraei, M Sheykhhasan, N Fayazi
Cellular Oncology 2021
Generation of Pure Highly Functional Human Anti-Tumor Specific Cytotoxic T Lymphocytes With Stem Cell-Like Memory Features for Melanoma Immunotherapy
M Hamieh, JF Chatillon, E Dupel, F Bayeux, E Fauquembergue, P Maby, A Drouet, AB Duval-Modeste, S Adriouch, O Boyer, JB Latouche
Frontiers in immunology 2021
PI3K in T Cell Adhesion and Trafficking
KH Johansen, DP Golec, JH Thomsen, PL Schwartzberg, K Okkenhaug
Frontiers in immunology 2021
In vitro OP9-DL1 co-culture and subsequent maturation in the presence of IL-21 generates tumor antigen-specific T cells with a favorable less-differentiated phenotype and enhanced functionality
S Bonte, S de Munter, L Billiet, G Goetgeluk, J Ingels, H Jansen, M Pille, L de Cock, K Weening, T Taghon, G Leclercq, B Vandekerckhove, T Kerre
OncoImmunology 2021
Memory stem T cells modified with a redesigned CD30‐chimeric antigen receptor show an enhanced antitumor effect in Hodgkin lymphoma
C AlvarezFernández, L EscribàGarcia, AC Caballero, E EscuderoLópez, C UjaldónMiró, R MontserratTorres, P PujolFernández, J Sierra, J Briones
IBMS BoneKEy 2021
Heterodimeric IL-15 in Cancer Immunotherapy
C Bergamaschi, V Stravokefalou, D Stellas, S Karaliota, BK Felber, GN Pavlakis
Cancers 2021
Genetic Modification of Tumor-Infiltrating Lymphocytes via Retroviral Transduction
H Weinstein-Marom, G Gross, M Levi, H Brayer, J Schachter, O Itzhaki, MJ Besser
Frontiers in immunology 2021
Prognostic and therapeutic TILs of cervical cancer—Current advances and future perspectives
Y Tang, AX Zhang, G Chen, Y Wu, W Gu
Molecular Therapy — Oncolytics 2021
Clonal expansion of T memory stem cells determines early anti-leukemic responses and long-term CAR T cell persistence in patients
L Biasco, N Izotova, C Rivat, S Ghorashian, R Richardson, A Guvenel, R Hough, R Wynn, B Popova, A Lopes, M Pule, AJ Thrasher, PJ Amrolia
2021
Chimeric antigen receptor T cells engineered to secrete CD40 agonist antibodies enhance antitumor efficacy
Y Zhang, P Wang, T Wang, Y Fang, Y Ding, Q Qian
Journal of Translational Medicine 2021
An overview of multiplexed analyses of CAR T-cell therapies: insights and potential
BP DePriest, N Vieira, A Bidgoli, S Paczesny
Expert Review of Proteomics 2021
Early Survival Prediction Framework in CD19-Specific CAR-T Cell Immunotherapy Using a Quantitative Systems Pharmacology Model
A Mueller-Schoell, N Puebla-Osorio, R Michelet, MR Green, A Künkele, W Huisinga, P Strati, B Chasen, SS Neelapu, C Yee, C Kloft
Cancers 2021
Optimizing the Clinical Impact of CAR-T Cell Therapy in B-Cell Acute Lymphoblastic Leukemia: Looking Back While Moving Forward
PS Kozani, PS Kozani, F Rahbarizadeh
Frontiers in immunology 2021
Targeted T cell receptor gene editing provides predictable T cell product function for immunotherapy
TR Müller, S Jarosch, M Hammel, J Leube, S Grassmann, B Bernard, M Effenberger, I Andrä, MZ Chaudhry, T Käuferle, A Malo, L Cicin-Sain, P Steinberger, T Feuchtinger, U Protzer, K Schumann, M Neuenhahn, K Schober, DH Busch
Reproduction 2021
Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. VII. Present and future of technologies for production of CAR cell therapies
RN Ramos, V Picanço-Castro, TG Oliveira, AM Junior, GC Santis, MH Bonamino, V Rocha
2021
T Cell Fitness and Autologous CAR T Cell Therapy in Haematologic Malignancy
PH Mehta, S Fiorenza, RM Koldej, A Jaworowski, DS Ritchie, KM Quinn
Frontiers in immunology 2021
Clinical Significance of Composition Changes in T-cell Subpopulations After Chemotherapy in Patients With Gastric Cancer
YEO MK, SUN P, CHUNG C, PARK JH, KANG SH, MOON HS, SUNG JK, JEONG HY, KIM JS
In vivo (Athens, Greece) 2021
Arming Immune Cell Therapeutics with Polymeric Prodrugs.
López CL, Brempelis KJ, Matthaei JF, Montgomery KS, Srinivasan S, Roy D, Huang F, Kreuser SA, Gardell JL, Blumenthal I, Chiefari J, Jensen MC, Crane CA, Stayton PS
Advanced Healthcare Materials 2021
Antigen-specific B-cell depletion for precision therapy of mucosal pemphigus vulgaris
Jinmin Lee, Daniel K. Lundgren, Xuming Mao, Silvio Manfredo-Vieira, Selene Nunez-Cruz, Erik F. Williams, Charles-Antoine Assenmacher, Enrico Radaelli, Sangwook Oh, Baomei Wang, Christoph T. Ellebrecht, Joseph A. Fraietta, Michael C. Miloneǂ, Aimee S. Payne
Journal of Clinical Investigation 2020
Single-cell transcriptomics identifies multiple pathways underlying antitumor function of TCR- and CD8αβ-engineered human CD4 + T cells
JA Rath, G Bajwa, B Carreres, E Hoyer, I Gruber, MA Martínez-Paniagua, YR Yu, N Nouraee, F Sadeghi, M Wu, T Wang, M Hebeisen, N Rufer, N Varadarajan, PC Ho, MK Brenner, D Gfeller, C Arber
Science Advances 2020
Adoptive Cell Therapy—Harnessing Antigen-Specific T Cells to Target Solid Tumours
E Chruściel, Z Urban-Wójciuk, Ł Arcimowicz, M Kurkowiak, J Kowalski, M Gliwiński, T Marjański, W Rzyman, W Biernat, R Dziadziuszko, C Montesano, R Bernardini, N Marek-Trzonkowska
Cancers 2020
Engineering T cells for immunotherapy of primary human hepatocellular carcinoma
LD Galva, L Cai, Y Shao, Y He
Journal of genetics and genomics = Yi chuan xue bao 2020
Engineering Solutions for Mitigation of Chimeric Antigen Receptor T-Cell Dysfunction
A Gavriil, M Barisa, E Halliwell, J Anderson
Cancers 2020
Memory T cells: strategies for optimizing tumor immunotherapy
Q Liu, Z Sun, L Chen
Protein & Cell 2020
Point-Of-Care CAR T-Cell Production (ARI-0001) Using a Closed Semi-automatic Bioreactor: Experience From an Academic Phase I Clinical Trial
M Castella, M Caballero-Baños, V Ortiz-Maldonado, EA González-Navarro, G Suñé, A Antoñana-Vidósola, A Boronat, B Marzal, L Millán, B Martín-Antonio, J Cid, M Lozano, E García, J Tabera, E Trias, U Perpiña, JM Canals, T Baumann, D Benítez-Ribas, E Campo, J Yagüe, Á Urbano-Ispizua, S Rives, J Delgado, M Juan
Frontiers in immunology 2020
TCR Redirected T Cells for Cancer Treatment: Achievements, Hurdles, and Goals
F Manfredi, BC Cianciotti, A Potenza, E Tassi, M Noviello, A Biondi, F Ciceri, C Bonini, E Ruggiero
Frontiers in immunology 2020
Current Advances in Osteosarcoma: Clinical Perspectives: Past, Present and Future
ES Kleinerman, R Gorlick
2020
‘Off-the-shelf’ allogeneic CAR T cells: development and challenges
S Depil, P Duchateau, SA Grupp, G Mufti, L Poirot
Nature Reviews Drug Discovery 2020
Human macrophages engineered to secrete a bispecific T cell engager support antigen-dependent T cell responses to glioblastoma
JL Gardell, LR Matsumoto, H Chinn, KR DeGolier, SA Kreuser, B Prieskorn, S Balcaitis, A Davis, RG Ellenbogen, CA Crane
Journal for ImmunoTherapy of Cancer 2020
Breaking Bottlenecks for the TCR Therapy of Cancer
L Gaissmaier, M Elshiaty, P Christopoulos
Cells 2020
Systematically optimized BCMA/CS1 bispecific CAR-T cells robustly control heterogeneous multiple myeloma
E Zah, E Nam, V Bhuvan, U Tran, BY Ji, SB Gosliner, X Wang, CE Brown, YY Chen
Nature Communications 2020
Minor Histocompatibility Antigen-Specific T Cells
C Summers, VS Sheth, M Bleakley
Frontiers in Pediatrics 2020
Humanized Mice Are Precious Tools for Preclinical Evaluation of CAR T and CAR NK Cell Therapies
R Mhaidly, E Verhoeyen
Cancers 2020
Orthotopic T-Cell Receptor Replacement—An “Enabler” for TCR-Based Therapies
K Schober, TR Müller, DH Busch
Cells 2020
Efficacy and safety of CD19 CAR T constructed with a new anti-CD19 chimeric antigen receptor in relapsed or refractory acute lymphoblastic leukemia
R Gu, F Liu, D Zou, Y Xu, Y Lu, B Liu, W Liu, X Chen, K Liu, Y Guo, X Gong, R Lv, X Chen, C Zhou, M Zhong, H Wang, H Wei, Y Mi, L Qiu, L Lv, M Wang, Y Wang, X Zhu, J Wang
Journal of Hematology & Oncology 2020
AIM Platform: A Novel Nano Artificial Antigen-Presenting Cell-Based Clinical System Designed to Consistently Produce Multi-Antigen-Specific T-Cell Products with Potent and Durable Anti-Tumor Properties
L Suarez, R Wang, S Carmer, D Bednarik, H Myint, K Jones, M Oelke
Transfusion Medicine and Hemotherapy 2020
A Bird’s-Eye View of Cell Sources for Cell-Based Therapies in Blood Cancers
B Motais, S Charvátová, M Hrdinka, M Šimíček, T Jelínek, T Ševčíková, Z Kořístek, R Hájek, JR Bagó
Cancers 2020
CARs: Beyond T Cells and T Cell-Derived Signaling Domains
NM Sievers, J Dörrie, N Schaft
International journal of molecular sciences 2020
CAR-T cells and TRUCKs that recognize an EBNA-3C-derived epitope presented on HLA-B*35 control Epstein-Barr virus-associated lymphoproliferation
AC Dragon, K Zimmermann, T Nerreter, D Sandfort, J Lahrberg, S Klöß, C Kloth, C Mangare, A Bonifacius, S Tischer-Zimmermann, R Blasczyk, B Maecker-Kolhoff, B Uchanska-Ziegler, H Abken, A Schambach, M Hudecek, B Eiz-Vesper
Journal for ImmunoTherapy of Cancer 2020
The Role of Circulating Tumor Cells in the Metastatic Cascade: Biology, Technical Challenges, and Clinical Relevance
H Dianat-Moghadam, M Azizi, Z Eslami-S, LE Cortés-Hernández, M Heidarifard, M Nouri, C Alix-Panabières
Cancers 2020
Modulating TNFα activity allows transgenic IL15-Expressing CLL-1 CAR T cells to safely eliminate acute myeloid leukemia
PA Atilla, MK McKenna, H Tashiro, M Srinivasan, F Mo, N Watanabe, BW Simons, AM Stevens, MS Redell, HE Heslop, M Mamonkin, MK Brenner, E Atilla
Journal for ImmunoTherapy of Cancer 2020
Profiling of immune dysfunction in COVID-19 patients allows early prediction of disease progression
AF Rendeiro, J Casano, CK Vorkas, H Singh, A Morales, RA DeSimone, GB Ellsworth, R Soave, SN Kapadia, K Saito, CD Brown, JM Hsu, C Kyriakides, S Chiu, LV Cappelli, MT Cacciapuoti, W Tam, L Galluzzi, PD Simonson, O Elemento, M Salvatore, G Inghirami
2020
Expamers: a new technology to control T cell activation
MP Poltorak, P Graef, C Tschulik, M Wagner, V Cletiu, S Dreher, B Borjan, SP Fraessle, M Effenberger, M Turk, DH Busch, J Plitzko, DG Kugler, S Ragan, T Schmidt, C Stemberger, L Germeroth
Scientific Reports 2020
Cancer testis antigen Cyclin A1 harbors several HLA-A*02:01-restricted T cell epitopes, which are presented and recognized in vivo
AT Teck, S Urban, P Quass, A Nelde, H Schuster, A Letsch, A Busse, JS Walz, U Keilholz, S Ochsenreither
Cancer Immunology, Immunotherapy 2020
Virus-Specific T Cell Therapies for HIV: Lessons Learned From Hematopoietic Stem Cell Transplantation
PH Lee, MD Keller, PJ Hanley, CM Bollard
Frontiers in Cellular and Infection Microbiology 2020
Ex vivo enrichment of PRAME antigen‐specific T cells for adoptive immunotherapy using CD137 activation marker selection
KH Lee, K Gowrishankar, J Street, HM McGuire, F Luciani, B Hughes, M Singh, LE Clancy, DJ Gottlieb, KP Micklethwaite, E Blyth
IBMS BoneKEy 2020
Dual Targeting of Mesothelin and CD19 with Chimeric Antigen Receptor-Modified T Cells in Patients with Metastatic Pancreatic Cancer
AH Ko, AC Jordan, E Tooker, SF Lacey, RB Chang, Y Li, AP Venook, M Tempero, L Damon, L Fong, MH OHara, BL Levine, JJ Melenhorst, G Plesa, CH June, GL Beatty
Molecular Therapy 2020
Clonal kinetics and single-cell transcriptional profiling of CAR-T cells in patients undergoing CD19 CAR-T immunotherapy
A Sheih, V Voillet, LA Hanafi, HA DeBerg, M Yajima, R Hawkins, V Gersuk, SR Riddell, DG Maloney, ME Wohlfahrt, D Pande, MR Enstrom, HP Kiem, JE Adair, R Gottardo, PS Linsley, CJ Turtle
Nature Communications 2020
Genetically engineered macrophages persist in solid tumors and locally deliver therapeutic proteins to activate immune responses
KJ Brempelis, CM Cowan, SA Kreuser, KP Labadie, BM Prieskorn, NA Lieberman, CI Ene, KW Moyes, H Chinn, KR DeGolier, LR Matsumoto, SK Daniel, JK Yokoyama, AD Davis, VJ Hoglund, KS Smythe, SD Balcaitis, MC Jensen, RG Ellenbogen, JS Campbell, RH Pierce, EC Holland, VG Pillarisetty, CA Crane
Journal for ImmunoTherapy of Cancer 2020
IL-2 enhances ex vivo–expanded regulatory T-cell persistence after adoptive transfer
SN Furlan, K Singh, C Lopez, V Tkachev, DJ Hunt, J Hibbard, KM Betz, BR Blazar, C Trapnell, LS Kean
Blood Advances 2020
Chimeric Antigen Receptor Based Therapy as a Potential Approach in Autoimmune Diseases: How Close Are We to the Treatment?
MS Nezhad, A Seifalian, N Bagheri, S Yaghoubi, MH Karimi, M Adbollahpour-Alitappeh
Frontiers in immunology 2020
The Art and Science of Selecting a CD123-Specific Chimeric Antigen Receptor for Clinical Testing
JM Riberdy, S Zhou, F Zheng, YI Kim, J Moore, A Vaidya, RE Throm, A Sykes, N Sahr, CL Bonifant, B Ryu, S Gottschalk, MP Velasquez
Molecular Therapy — Methods & Clinical Development 2020
Effect of Cellular-Based Artificial Antigen Presenting Cells Expressing ICOSL, in T-cell Subtypes Differentiation and Activation
Talebi M, Nozad Charoudeh H, Movassaghpour Akbari AA, Baradaran B, Kazemi T
Advanced pharmaceutical bulletin 2020
Acellular Wharton’s Jelly, Potentials in T-Cell Subtypes Differentiation, Activation and Proliferation
Talebi M, Nozad Charoudeh H, Movassaghpour Akbari AA, Baradaran B, Kazemi T
Advanced pharmaceutical bulletin 2020
Longitudinal immune profiling of mild and severe COVID-19 reveals innate and adaptive immune dysfunction and provides an early prediction tool for clinical progression
Rendeiro AF, Casano J, Kyriakos Vorkas C, Singh H, Morales A, DeSimone RA, Ellsworth GB, Soave R, Kapadia SN, Saito K, Brown CD, Hsu J, Kyriakides C, Chiu S, Cappelli L, Teresa Cacciapuoti M, Tam W, Galluzzi L, Simonson PD, Elemento O, Salvatore M, Inghirami G
2020
Improving CAR T cell immunotherapy-mediated remissions for pediatric Leukemia
David Barrett
Journal of Clinical Investigation 2019
CD19 CAR T cell product and disease attributes predict leukemia remission durability
Olivia C. Finney, Hannah M Brakke, Stephanie Rawlings-Rhea, Roxana Hicks, Danielle Doolittle, Marisa Lopez, Robert B. Futrell, Rimas J. Orentas, Daniel Li, Rebecca A Gardner, Michael C Jensen
Journal of Clinical Investigation 2019
CD19-targeting CAR T cell immunotherapy outcomes correlate with genomic modification by vector integration
Christopher L Nobles, Scott Sherrill-Mix, John K. Everett, Shantan Reddy, Joseph Fraietta, David Porter, Noelle Frey, Saar Gill, Stephan Grupp, Shannon L Maude, Don L Siegel, Bruce L Levine, Carl H. June, Simon F. Lacey, J. Joseph Melenhorst, Frederic Bushman
Journal of Clinical Investigation 2019
Surface-Engineered Lentiviral Vectors for Selective Gene Transfer into Subtypes of Lymphocytes
AM Frank, CJ Buchholz
Molecular Therapy — Methods & Clinical Development 2019
The making and function of CAR cells
M Zabel, PA Tauber, WF Pickl
Immunology Letters 2019
A long way to the battlefront: CAR T cell therapy against solid cancers
Z Wang, W Chen, X Zhang, Z Cai, W Huang
Journal of Cancer 2019
Baboon envelope LVs efficiently transduced human adult, fetal, and progenitor T cells and corrected SCID-X1 T-cell deficiency
O Bernadin, F Amirache, A Girard-Gagnepain, RD Moirangthem, C Lévy, K Ma, C Costa, D Nègre, C Reimann, D Fenard, A Cieslak, V Asnafi, H Sadek, R Mhaidly, M Cavazzana, C Lagresle-Peyrou, FL Cosset, I André, E Verhoeyen
Blood Advances 2019
Engineering for Success: Approaches to Improve Chimeric Antigen Receptor T Cell Therapy for Solid Tumors
M Mata, S Gottschalk
Drugs 2019
Multispecific Targeting with Synthetic Ankyrin Repeat Motif Chimeric Antigen Receptors
A Balakrishnan, A Rajan, AI Salter, PL Kosasih, Q Wu, J Voutsinas, MC Jensen, A Plückthun, SR Riddell
Clinical cancer research 2019
Targeted in-vitro-stimulation reveals highly proliferative multi-virus-specific human central memory T cells as candidates for prophylactic T cell therapy
B Faist, F Schlott, C Stemberger, KM Dennehy, A Krackhardt, M Verbeek, GU Grigoleit, M Schiemann, D Hoffmann, A Dick, K Martin, M Hildebrandt, DH Busch, M Neuenhahn, M Nevels
PloS one 2019
Switching on the green light for chimeric antigen receptor T-cell therapy
S Mardiana, J Lai, IG House, PA Beavis, PK Darcy
IBMS BoneKEy 2019
T cell immunotherapy enhanced by designer biomaterials
ZS Dunn, J Mac, P Wang
Biomaterials 2019
IL15 Enhances CAR-T Cell Antitumor Activity by Reducing mTORC1 Activity and Preserving Their Stem Cell Memory Phenotype
D Alizadeh, RA Wong, X Yang, D Wang, JR Pecoraro, CF Kuo, B Aguilar, Y Qi, DK Ann, R Starr, R Urak, X Wang, SJ Forman, CE Brown
Cancer immunology research 2019
Toward the development of true “off-the-shelf” synthetic T-cell immunotherapy
S Iriguchi, S Kaneko
Cancer Science 2019
CAR T Cells: A Snapshot on the Growing Options to Design a CAR
A Holzinger, H Abken
2019
Expansion and activation of distinct central memory T lymphocyte subsets in complex regional pain syndrome
MA Russo, NT Fiore, C van Vreden, D Bailey, DM Santarelli, HM McGuire, BF de St Groth, PJ Austin
Journal of Neuroinflammation 2019
Engineering an Artificial T‐Cell Stimulating Matrix for Immunotherapy
JW Hickey, Y Dong, JW Chung, SF Salathe, HC Pruitt, X Li, C Chang, AK Fraser, CA Bessell, AJ Ewald, S Gerecht, HQ Mao, JP Schneck
Advanced materials (Deerfield Beach, Fla.) 2019
Hypoxia Selectively Impairs CAR-T Cells In Vitro
R Berahovich, X Liu, H Zhou, E Tsadik, S Xu, V Golubovskaya, L Wu
Cancers 2019
Comprehensive Characterization of a Next-Generation Antiviral T-Cell Product and Feasibility for Application in Immunosuppressed Transplant Patients
L Amini, T Vollmer, DJ Wendering, A Jurisch, S Landwehr-Kenzel, NM Otto, K Jürchott, HD Volk, P Reinke, M Schmueck-Henneresse
Frontiers in immunology 2019
Large-scale expansion and characterization of CD3+ T-cells in the Quantum® Cell Expansion System
C Coeshott, B Vang, M Jones, B Nankervis
Journal of Translational Medicine 2019
Human Platelet Lysate Media Supplement Supports Lentiviral Transduction and Expansion of Human T Lymphocytes While Maintaining Memory Phenotype
E Canestrari, HR Steidinger, B McSwain, SJ Charlebois, CT Dann
Journal of Immunology Research 2019
Mycobacterium indicus pranii Induced Memory T-Cells in Lung Airways Are Sentinels for Improved Protection Against M.tb Infection
A Gupta, M Saqib, B Singh, L Pal, A Nishikanta, S Bhaskar
Frontiers in immunology 2019
T cell receptor gene therapy targeting WT1 prevents acute myeloid leukemia relapse post-transplant
AG Chapuis, DN Egan, M Bar, TM Schmitt, MS McAfee, KG Paulson, V Voillet, R Gottardo, GB Ragnarsson, M Bleakley, CC Yeung, P Muhlhauser, HN Nguyen, LA Kropp, L Castelli, F Wagener, D Hunter, M Lindberg, K Cohen, A Seese, MJ McElrath, N Duerkopp, TA Gooley, PD Greenberg
Nature Medicine 2019
S-15 in combination of Akt inhibitor promotes the expansion of CD45RA−CCR7+ tumor infiltrating lymphocytes with high cytotoxic potential and downregulating PD-1+Tim-3+ cells as well as regulatory T cells
B Xu, L Yuan, G Chen, T Li, J Zhou, C Zhang, P Qin, MM Muthana, S Wang, X Du, Q Gao
Cancer Cell International 2019
Activated Allogeneic Donor-derived Marrow-infiltrating Lymphocytes Display Measurable In Vitro Antitumor Activity
Biavati L, Noonan K, Luznik L, Borrello I
Journal of immunotherapy (Hagerstown, Md. : 1997) 2019
Glioblastoma-Targeted CD4+ CAR-T cells outperform CD8+ cells for Sustained Effector Function and Superior Antitumor Activity
Dongrui Wang, Brenda Aguilar, Renate Starr, Darya Alizadeh, Alfonso Brito, Aniee Sarkissian, Julie Ostberg, Stephen J. Forman, Christine Brown
JCI Insight 2018
Reducing Ex Vivo Culture Improves the Antileukemic Activity of Chimeric Antigen Receptor (CAR) T Cells
S Ghassemi, S Nunez-Cruz, RS O'Connor, JA Fraietta, PR Patel, J Scholler, DM Barrett, SM Lundh, MM Davis, F Bedoya, C Zhang, J Leferovich, SF Lacey, BL Levine, SA Grupp, CH June, JJ Melenhorst, MC Milone
Cancer immunology research 2018
A primary role for human central memory cells in tissue immunosurveillance
A Gehad, JE Teague, TR Matos, V Huang, C Yang, R Watanabe, JT OMalley, CL Trimble, TS Kupper, RA Clark
Blood Advances 2018
Adoptive cancer immunotherapy using DNA-demethylated T helper cells as antigen-presenting cells
AF Kirkin, KN Dzhandzhugazyan, P Guldberg, JJ Fang, RS Andersen, C Dahl, J Mortensen, T Lundby, A Wagner, I Law, H Broholm, L Madsen, C Lundell-Ek, MF Gjerstorff, HJ Ditzel, MR Jensen, W Fischer
Nature Communications 2018
Circulating T Cell Subpopulations Correlate With Immune Responses at the Tumor Site and Clinical Response to PD1 Inhibition in Non-Small Cell Lung Cancer
N Manjarrez-Orduño, LC Menard, S Kansal, P Fischer, B Kakrecha, C Jiang, M Cunningham, D Greenawalt, V Patel, M Yang, R Golhar, JA Carman, S Lezhnin, H Dai, PS Kayne, SJ Suchard, SH Bernstein, SG Nadler
Frontiers in immunology 2018
Clinical translation and regulatory aspects of CAR/TCR-based adoptive cell therapies—the German Cancer Consortium approach
AM Krackhardt, B Anliker, M Hildebrandt, M Bachmann, SB Eichmüller, DM Nettelbeck, M Renner, L Uharek, G Willimsky, M Schmitt, WS Wels, M Schüssler-Lenz
Cancer Immunology, Immunotherapy 2018
The Pharmacology of T Cell Therapies
MC Milone, VG Bhoj
Molecular Therapy — Methods & Clinical Development 2018
Optimization of IL13Rα2-Targeted Chimeric Antigen Receptor T Cells for Improved Anti-tumor Efficacy against Glioblastoma
CE Brown, B Aguilar, R Starr, X Yang, WC Chang, L Weng, B Chang, A Sarkissian, A Brito, JF Sanchez, JR Ostberg, M DApuzzo, B Badie, ME Barish, SJ Forman
Molecular Therapy 2018
Receptor-Targeted Glial Brain Tumor Therapies
P Sharma, W Debinski
International journal of molecular sciences 2018
Chimeric antigen receptor–modified T cells: CD19 and the road beyond
AI Salter, MJ Pont, SR Riddell
Blood 2018
Defining success with cellular therapeutics: the current landscape for clinical end point and toxicity analysis:
LS Kean
Blood 2018
CD19 Chimeric Antigen Receptor T Cells From Patients With Chronic Lymphocytic Leukemia Display an Elevated IFN-γ Production Profile:
I Magalhaes, I Kalland, JN Kochenderfer, A Österborg, M Uhlin, J Mattsson
Journal of immunotherapy (Hagerstown, Md. : 1997) 2018
Preclinical Optimization of a CD20-specific Chimeric Antigen Receptor Vector and Culture Conditions:
SY Lee, P Olsen, DH Lee, AL Kenoyer, LE Budde, S OSteen, DJ Green, S Heimfeld, MC Jensen, SR Riddell, OW Press, BG Till
Journal of immunotherapy (Hagerstown, Md. : 1997) 2018
Th9 Cells Represent a Unique Subset of CD4 + T Cells Endowed with the Ability to Eradicate Advanced Tumors
Y Lu, Q Wang, G Xue, E Bi, X Ma, A Wang, J Qian, C Dong, Q Yi
Cancer Cell 2018
Chimeric Antigen Receptor T Cell Therapy: Challenges to Bench-to-Bedside Efficacy
S Srivastava, SR Riddell
Journal of immunology (Baltimore, Md. : 1950) 2018
Chimeric Antigen Receptor T Cell-Mediated Neurotoxicity in Non-Human Primates
A Taraseviciute, V Tkachev, R Ponce, CJ Turtle, JM Snyder, HD Liggitt, D Myerson, L Gonzalez-Cuyar, A Baldessari, C English, A Yu, H Zheng, SN Furlan, DJ Hunt, V Hoglund, O Finney, H Brakke, BR Blazar, C Berger, S Riddell, R Gardner, LS Kean, MC Jensen
Cancer Discovery 2018
Characterization and clinical enrichment of HLA-C*07:02-restricted Cytomegalovirus-specific CD8+ T cells
F Schlott, D Steubl, S Ameres, A Moosmann, S Dreher, U Heemann, V Hösel, DH Busch, M Neuenhahn, M Nevels
PloS one 2018
Efficient Enrichment of Gene-Modified Primary T Cells via CCR5-Targeted Integration of Mutant Dihydrofolate Reductase
B Paul, GS Ibarra, N Hubbard, T Einhaus, A Astrakhan, DJ Rawlings, HP Kiem, CW Peterson
Molecular Therapy — Methods & Clinical Development 2018
Expansion of Gammadelta T Cells from Cord Blood: A Therapeutical Possibility
S Berglund, A Gaballa, P Sawaisorn, B Sundberg, M Uhlin
Stem Cells International 2018
CRISPR therapeutic tools for complex genetic disorders and cancer (Review)
S Baliou, M Adamaki, A Kyriakopoulos, D Spandidos, M Panagiotidis, I Christodoulou, V Zoumpourlis
International journal of oncology 2018
Cytomegalovirus infection and progressive differentiation of effector-memory T cells
IN Pardieck, G Beyrend, A Redeker, R Arens
F1000Research 2018
Efficient magnetic enrichment of antigen-specific T cells by engineering particle properties
JW Hickey, AY Isser, FP Vicente, SB Warner, HQ Mao, JP Schneck
Biomaterials 2018
Chimeric Antigen Receptors Based on Low Affinity Mutants of FcεRI Re-direct T Cell Specificity to Cells Expressing Membrane IgE
DE Ward, BL Fay, A Adejuwon, H Han, Z Ma
Frontiers in immunology 2018
Virus-Specific T Cells: Current and Future Use in Primary Immunodeficiency Disorders
KM Harris, BJ Davila, CM Bollard, MD Keller
The Journal of Allergy and Clinical Immunology: In Practice 2018
Cell‐Templated Silica Microparticles with Supported Lipid Bilayers as Artificial Antigen‐Presenting Cells for T Cell Activation
BR Olden, CR Perez, AL Wilson, II Cardle, YS Lin, B Kaehr, JA Gustafson, MC Jensen, SH Pun
Advanced Healthcare Materials 2018
Eomesodermin driven IL-10 production in effector CD8+ T cells promotes a memory phenotype
J Reiser, K Sadashivaiah, A Furusawa, A Banerjee, N Singh
Cellular Immunology 2018
T-cell functionality testing is highly relevant to developing novel immuno-tracers monitoring T cells in the context of immunotherapies and revealed CD7 as an attractive target
KE Mayer, S Mall, N Yusufi, D Gosmann, K Steiger, L Russelli, H de Oliviera Bianchi, S Audehm, R Wagner, E Bräunlein, A Stelzl, F Bassermann, W Weichert, W Weber, M Schwaiger, C D'Alessandria, AM Krackhardt
Theranostics 2018
CTL019 (tisagenlecleucel): CAR-T therapy for relapsed and refractory B-cell acute lymphoblastic leukemia
S Vairy, JL Garcia, P Teira, H Bittencourt
Drug design, development and therapy 2018
Specific Adoptive T-Cell Therapy for Viral and Fungal Infections
Lum LG, Bollard CM
2018
Th17 cells are refractory to senescence retaining robust antitumor activity after long-term ex vivo expansion
Jacob Bowers, Michelle H. Nelson, Kinga Majchrzak, Stefanie Bailey, Barbel Rohrer, Andrew Kaiser, Carl Atkinson, Luca Gattinoni, Chrystal Paulos
JCI Insight 2017
Pharmacologic inhibition of β-catenin and PI3Kδ paradoxically expands precursor Th17 cells with heightened stemness and antitumor activity
Kinga Majchrzak, Michelle H. Nelson, Jacob Bowers, Stefanie Bailey, Megan Meek, John Wrangle, Juan Varela, Mark Rubinstein, zihai Li, Richard Himes, Sherine Chan, Chrystal Paulos
JCI Insight 2017
Fine-tuning the CAR spacer improves T-cell potency
N Watanabe, P Bajgain, S Sukumaran, S Ansari, HE Heslop, CM Rooney, MK Brenner, AM Leen, JF Vera
OncoImmunology 2017
PI3Kδ Inhibition Enhances the Antitumor Fitness of Adoptively Transferred CD8+ T Cells
JS Bowers, K Majchrzak, MH Nelson, BA Aksoy, MM Wyatt, AS Smith, SR Bailey, LR Neal, JE Hammerbacher, CM Paulos
Frontiers in immunology 2017
Comprehensive Approach for Identifying the T Cell Subset Origin of CD3 and CD28 Antibody–Activated Chimeric Antigen Receptor–Modified T Cells
M Schmueck-Henneresse, B Omer, T Shum, H Tashiro, M Mamonkin, N Lapteva, S Sharma, L Rollins, G Dotti, P Reinke, HD Volk, CM Rooney
Journal of immunology (Baltimore, Md. : 1950) 2017
Multifaceted Role of BTLA in the Control of CD8 + T-cell Fate after Antigen Encounter
K Ritthipichai, CL Haymaker, M Martinez, A Aschenbrenner, X Yi, M Zhang, C Kale, LM Vence, J Roszik, Y Hailemichael, WW Overwijk, N Varadarajan, R Nurieva, LG Radvanyi, P Hwu, C Bernatchez
Clinical cancer research 2017
T memory stem cells in health and disease
L Gattinoni, DE Speiser, M Lichterfeld, C Bonini
Nature Medicine 2017
Systematic evaluation of immune regulation and modulation
DF Stroncek, LH Butterfield, MA Cannarile, MV Dhodapkar, TF Greten, JC Grivel, DR Kaufman, HH Kong, F Korangy, PP Lee, F Marincola, S Rutella, JC Siebert, G Trinchieri, B Seliger
Journal for ImmunoTherapy of Cancer 2017
Chimeric Antigen Receptors: A Cell and Gene Therapy Perspective
I Rivière, M Sadelain
Molecular Therapy 2017
Therapeutic T cell engineering
M Sadelain, I Rivière, S Riddell
Nature 2017
CARs: Synthetic Immunoreceptors for Cancer Therapy and Beyond
ZN Chang, YY Chen
Trends in Molecular Medicine 2017
Building upon the success of CART19: chimeric antigen receptor T cells for hematologic malignancies
A Rotolo, A Karadimitris, M Ruella
Leukemia & Lymphoma 2017
Development of T cell immunotherapy for hematopoietic stem cell transplantation recipients at risk of leukemia relapse
RG Dossa, T Cunningham, D Sommermeyer, I Medina-Rodriguez, MA Biernacki, K Foster, M Bleakley
Blood 2017
Immunotherapy of cancer: targeting cancer during active disease or during dormancy?
SA Shah, M Zarei, SH Manjili, G Guruli, XY Wang, MH Manjili
Immunotherapy 2017
CCR7+ selected gene-modified T cells maintain a central memory phenotype and display enhanced persistence in peripheral blood in vivo
G Kueberuwa, H Gornall, EM Alcantar-Orozco, D Bouvier, ZA Kapacee, RE Hawkins, DE Gilham
Journal for ImmunoTherapy of Cancer 2017
Ex vivo Akt inhibition promotes the generation of potent CD19CAR T cells for adoptive immunotherapy
R Urak, M Walter, L Lim, CL Wong, LE Budde, S Thomas, SJ Forman, X Wang
Journal for ImmunoTherapy of Cancer 2017
Cell-Mediated Immunity to Target the Persistent Human Immunodeficiency Virus Reservoir
JL Riley, LJ Montaner
The Journal of Infectious Diseases 2017
Tracking the fate and origin of clinically relevant adoptively transferred CD8 + T cells in vivo
AG Chapuis, C Desmarais, R Emerson, TM Schmitt, KC Shibuya, IP Lai, F Wagener, J Chou, IM Roberts, DG Coffey, EH Warren, H Robins, PD Greenberg, C Yee
Science Immunology 2017
Curtailed T-cell activation curbs effector differentiation and generates CD8 + T cells with a naturally-occurring memory stem cell phenotype
V Zanon, K Pilipow, E Scamardella, FD Paoli, GD Simone, DA Price, AM Usatorre, P Romero, D Mavilio, A Roberto, E Lugli
European Journal of Immunology 2017
Predictive factors of the tumor immunological microenvironment for long-term follow-up in early stage breast cancer
M Okabe, U Toh, N Iwakuma, S Saku, M Akashi, Y Kimitsuki, N Seki, A Kawahara, E Ogo, K Itoh, Y Akagi
Cancer Science 2017
Differential cytokine withdrawal-induced death sensitivity of effector T cells derived from distinct human CD8+ memory subsets
SE Larsen, K Voss, ED Laing, AL Snow
Cell Death Discovery 2017
Considerations in T Cell Therapy Product Development for B Cell Leukemia and Lymphoma Immunotherapy
AD Fesnak, PJ Hanley, BL Levine
Current Hematologic Malignancy Reports 2017
Anti-CD 19 and anti-CD 20 CAR-modified T cells for B-cell malignancies: a systematic review and meta-analysis
IB Riaz, U Zahid, MU Kamal, M Husnain, A McBride, A Hua, AA Hamadani, L George, A Zeeshan, QA Sipra, A Raina, B Rahman, S Puvvada, F Anwer
Immunotherapy 2017
Different death destinies: relative apoptosis sensitivity shapes the human effector CD8+ T-cell response derived from distinct memory subsets
AL Snow, SE Larsen
Cell Death and Disease 2017
Polyfunctional response by ImmTAC (IMCgp100) redirected CD8 + and CD4 + T cells
C Boudousquie, G Bossi, JM Hurst, KA Rygiel, BK Jakobsen, NJ Hassan
Immunology 2017
Robust Production of Cytomegalovirus pp65-Specific T Cells Using a Fully Automated IFN-γ Cytokine Capture System
N Kim, YS Nam, KI Im, JY Lim, YW Jeon, Y Song, JW Lee, SG Cho
Transfusion Medicine and Hemotherapy 2017
特异性人工抗原提呈细胞体外激活CD19嵌合抗原受体T细胞的构建
2017
CD19 CAR-T cells of defined CD4+:CD8+ composition for adult B-cell ALL
Cameron Turtle, Laïla-Aïcha Hanafi, Carolina Berger, Theodore Gooley, Sindhu Cherian, Michael Hudecek, Daniel Sommermeyer, Katherine Melville, Pender Barbara, Tanya Budiarto, Emily Robinson, Natalia Steevens, Colette Chaney, Lorinda Soma, Xueyan Chen, Cecilia Yeung, Brent Wood, Daniel Li, Jianhong Cao, Shelly Heimfeld, Michael C. Jensen, Stanley R. Riddell, David Maloney
Journal of Clinical Investigation 2016
BET bromodomain inhibition generates superior T cells for adoptive immunotherapy
Yuki Kagoya, Munehide Nakatsugawa, Yuki Yamashita, Toshiki Ochi, Tingxi Guo, Mark Anczurowski, Kayoko Saso, Marcus Butler, Cheryl Arrowsmith, Naoto Hirano
Journal of Clinical Investigation 2016
Heterodimeric IL15 Treatment Enhances Tumor Infiltration, Persistence, and Effector Functions of Adoptively Transferred Tumor-specific T Cells in the Absence of Lymphodepletion
SS Ng, BA Nagy, SM Jensen, X Hu, C Alicea, BA Fox, BK Felber, C Bergamaschi, GN Pavlakis
Clinical cancer research 2016
Role of memory T cell subsets for adoptive immunotherapy
DH Busch, SP Fräßle, D Sommermeyer, VR Buchholz, SR Riddell
Seminars in Immunology 2016
Tethered IL-15 augments antitumor activity and promotes a stem-cell memory subset in tumor-specific T cells
LV Hurton, H Singh, AM Najjar, KC Switzer, T Mi, S Maiti, S Olivares, B Rabinovich, H Huls, MA Forget, V Datar, P Kebriaei, DA Lee, RE Champlin, LJ Cooper
Proceedings of the National Academy of Sciences 2016
Driving gene-engineered T cell immunotherapy of cancer
LA Johnson, CH June
Cell Research 2016
Improving Adoptive T Cell Therapy: The Particular Role of T Cell Costimulation, Cytokines, and Post-Transfer Vaccination
A Redeker, R Arens
Frontiers in immunology 2016
Marrow-Infiltrating Lymphocytes – Role in Biology and Cancer Therapy
I Borrello, KA Noonan
Frontiers in immunology 2016
Recent Developments in Cellular Immunotherapy for HSCT-Associated Complications
M Reis, J Ogonek, M Qesari, NM Borges, L Nicholson, L Preußner, AM Dickinson, X Wang, EM Weissinger, A Richter
Frontiers in immunology 2016
Constitutive Lck Activity Drives Sensitivity Differences between CD8+ Memory T Cell Subsets
D Moogk, S Zhong, Z Yu, I Liadi, W Rittase, V Fang, J Dougherty, A Perez-Garcia, I Osman, C Zhu, N Varadarajan, NP Restifo, AB Frey, M Krogsgaard
Journal of immunology (Baltimore, Md. : 1950) 2016
Improving therapy of chronic lymphocytic leukemia with chimeric antigen receptor T cells
JA Fraietta, RD Schwab, MV Maus
Seminars in Oncology 2016
Reprogramming of Melanoma Tumor-Infiltrating Lymphocytes to Induced Pluripotent Stem Cells
H Saito, K Okita, N Fusaki, MS Sabel, AE Chang, F Ito
Stem Cells International 2016
Soluble and membrane-bound interleukin (IL)-15 R α /IL-15 complexes mediate proliferation of high-avidity central memory CD8 + T cells for adoptive immunotherapy of cancer and infections: IL-15Rα/IL-15 & memory T cell avidity
AN Hasan, A Selvakumar, E Shabrova, XR Liu, F Afridi, G Heller, I Riviere, M Sadelain, B Dupont, RJ O'Reilly
Clinical & Experimental Immunology 2016
T Cell Maturation Stage Prior to and During GMP Processing Informs on CAR T Cell Expansion in Patients
Y Klaver, SC van Steenbergen, S Sleijfer, R Debets, CH Lamers
Frontiers in immunology 2016
CMV-Specific CD8 T Cell Differentiation and Localization: Implications for Adoptive Therapies
CJ Smith, M Quinn, CM Snyder
Frontiers in immunology 2016
Adoptive Transfer of Engineered Rhesus Simian Immunodeficiency Virus-Specific CD8 + T Cells Reduces the Number of Transmitted/Founder Viruses Established in Rhesus Macaques
VI Ayala, MT Trivett, EV Barsov, S Jain, M Piatak, CM Trubey, WG Alvord, E Chertova, JD Roser, J Smedley, A Komin, BF Keele, C Ohlen, DE Ott, G Silvestri
Journal of virology 2016
Phase 1 studies of central memory-derived CD19 CAR T-cell therapy following autologous HSCT in patients with B-cell NHL
X Wang, LL Popplewell, JR Wagner, A Naranjo, MS Blanchard, MR Mott, AP Norris, CW Wong, RZ Urak, WC Chang, SK Khaled, T Siddiqi, LE Budde, J Xu, B Chang, N Gidwaney, SH Thomas, LJ Cooper, SR Riddell, CE Brown, MC Jensen, SJ Forman
Blood 2016
A short CD3/CD28 costimulation combined with IL-21 enhance the generation of human memory stem T cells for adoptive immunotherapy
C Alvarez-Fernández, L Escribà-Garcia, S Vidal, J Sierra, J Briones
Journal of Translational Medicine 2016
Immunotherapy of non-Hodgkins lymphoma with a defined ratio of CD8+ and CD4+ CD19-specific chimeric antigen receptor-modified T cells
CJ Turtle, LA Hanafi, C Berger, M Hudecek, B Pender, E Robinson, R Hawkins, C Chaney, S Cherian, X Chen, L Soma, B Wood, D Li, S Heimfeld, SR Riddell, DG Maloney
Science Translational Medicine 2016
Clinical manufacturing of CAR T cells: foundation of a promising therapy
X Wang, I Rivière
Molecular Therapy — Oncolytics 2016
Modulation of mTOR Signalling Triggers the Formation of Stem Cell-like Memory T Cells
G Scholz, C Jandus, L Zhang, C Grandclément, IC Lopez-Mejia, C Soneson, M Delorenzi, L Fajas, W Held, O Dormond, P Romero
EBioMedicine 2016
Cytomegalovirus and immunotherapy: opportunistic pathogen, novel target for cancer and a promising vaccine vector
M Quinn, DA Erkes, CM Snyder
Immunotherapy 2016
Naïve CD8+ T cell derived tumor-specific cytotoxic effectors as a potential remedy for overcoming TGF-β immunosuppression in the tumor microenvironment
HH Nguyen, T Kim, SY Song, S Park, HH Cho, SH Jung, JS Ahn, HJ Kim, JJ Lee, HO Kim, JH Cho, DH Yang
Scientific Reports 2016
Virus-specific T-cell banks for 'off the shelf' adoptive therapy of refractory infections
RJ O'Reilly, S Prockop, AN Hasan, G Koehne, E Doubrovina
Bone Marrow Transplantation 2016
T-cell therapies for HIV: Preclinical successes and current clinical strategies
S Patel, RB Jones, DF Nixon, CM Bollard
Cytotherapy 2016
CAR T Cell Therapy: A Game Changer in Cancer Treatment
H Almåsbak, T Aarvak, MC Vemuri
Journal of Immunology Research 2016
T cells for viral infections after allogeneic hematopoietic stem cell transplant
CM Bollard, HE Heslop
Blood 2016
Different Subsets of T Cells, Memory, Effector Functions, and CAR-T Immunotherapy
V Golubovskaya, L Wu
Cancers 2016
Redirecting Specificity of T cells Using the Sleeping Beauty System to Express Chimeric Antigen Receptors by Mix-and-Matching of VL and VH Domains Targeting CD123+ Tumors
R Thokala, S Olivares, T Mi, S Maiti, D Deniger, H Huls, H Torikai, H Singh, RE Champlin, T Laskowski, G McNamara, LJ Cooper, D Unutmaz
PloS one 2016
Chimeric Antigen Receptors Modified T-Cells for Cancer Therapy
Hanren Dai, Yao Wang, Xuechun Lu, Weidong Han
JNCI Journal of the National Cancer Institute 2016
L1 Cell Adhesion Molecule-Specific Chimeric Antigen Receptor-Redirected Human T Cells Exhibit Specific and Efficient Antitumor Activity against Human Ovarian Cancer in Mice
H Hong, CE Brown, JR Ostberg, SJ Priceman, WC Chang, L Weng, P Lin, MT Wakabayashi, MC Jensen, SJ Forman, N Gangopadhyay
PloS one 2016
Immunotherapy of Malignant Tumors in the Brain: How Different from Other Sites?
V Dutoit, D Migliorini, PY Dietrich, PR Walker
Frontiers in Oncology 2016
Technical Considerations for the Generation of Adoptively Transferred T Cells in Cancer Immunotherapy
A Visioni, J Skitzki
Cancers 2016
Immunological quality and performance of tumor vessel-targeting CAR-T cells prepared by mRNA-EP for clinical research
K Inoo, R Inagaki, K Fujiwara, S Sasawatari, T Kamigaki, S Nakagawa, N Okada
Molecular Therapy - Oncolytics 2016
Tumor-infiltrating lymphocytes (TILs) from patients with glioma
Z Liu, Q Meng, J Bartek, T Poiret, O Persson, L Rane, E Rangelova, C Illies, IH Peredo, X Luo, MV Rao, RA Robertson, E Dodoo, M Maeurer
OncoImmunology 2016
Quorum-like behavior between T-cell subsets enhances differentiation impairing cellular immunotherapy
Christopher A. Klebanoff, Christopher Scott, Anthony Leonardi, Tori Yamamoto, Anthony Cruz, Claudia Ouyang, Madhu Ramaswamy, Rahul Roychoudhuri, Yun Ji, Robert Eil, Madhusudhanan Sukumar, Joseph G. Crompton, Douglas C. Palmer, Zachary Borman, David Clever, Stacy K. Thomas, Shashank Patel, Zhiya Yu, Pawel Muranski, Hui Liu, Ena Wang, Francesco Marincola, Alena Gros, Luca Gattinoni, Steven Rosenberg, Richard Siegel, Nicholas Restifo
Journal of Clinical Investigation 2015
Chimeric antigen receptor-modified T cells derived from defined CD8+ and CD4+ subsets confer superior antitumor reactivity in vivo
D Sommermeyer, M Hudecek, PL Kosasih, T Gogishvili, DG Maloney, CJ Turtle, SR Riddell
Leukemia 2015
T-cell receptor gene therapy - ready to go viral?
T Karpanen, J Olweus
Molecular Oncology 2015
CMV-specific T cells generated from naive T cells recognize atypical epitopes and may be protective in vivo
PJ Hanley, JJ Melenhorst, S Nikiforow, P Scheinberg, JW Blaney, G Demmler-Harrison, CR Cruz, S Lam, RA Krance, KS Leung, CA Martinez, H Liu, DC Douek, HE Heslop, CM Rooney, EJ Shpall, AJ Barrett, JR Rodgers, CM Bollard
Science Translational Medicine 2015
Adoptive transfer of activated marrow-infiltrating lymphocytes induces measurable antitumor immunity in the bone marrow in multiple myeloma
KA Noonan, CA Huff, J Davis, MV Lemas, S Fiorino, J Bitzan, A Ferguson, A Emerling, L Luznik, W Matsui, J Powell, E Fuchs, GL Rosner, C Epstein, L Rudraraju, RF Ambinder, RJ Jones, D Pardoll, I Borrello
Science Translational Medicine 2015
Generation of memory T cells for adoptive transfer using clinical-grade anti-CD62L magnetic beads
S Verfuerth, PS Sousa, L Beloki, M Murray, MD Peters, S Mackinnon, MW Lowdell, R Chakraverty, ER Samuel
Bone Marrow Transplantation 2015
Chimeric Antigen Receptor- and TCR-Modified T Cells Enter Main Street and Wall Street
DM Barrett, SA Grupp, CH June
Journal of immunology (Baltimore, Md. : 1950) 2015
Towards a commercial process for the manufacture of genetically modified T cells for therapy
AD Kaiser, M Assenmacher, B Schröder, M Meyer, R Orentas, U Bethke, B Dropulic
Cancer Gene Therapy 2015
Adoptive cell transfer as personalized immunotherapy for human cancer
SA Rosenberg, NP Restifo
Science 2015
Genetically modified T cells in cancer therapy: opportunities and challenges
M Sharpe, N Mount
Disease models & mechanisms 2015
Synthetic biology in cell-based cancer immunotherapy
D Chakravarti, WW Wong
Trends in Biotechnology 2015
Comparison of Naïve and Central Memory Derived CD8 + Effector Cell Engraftment Fitness and Function Following Adoptive Transfer
X Wang, CL Wong, R Urak, E Taus, B Aguilar, WC Chang, A Mardiros, LE Budde, CE Brown, C Berger, SJ Forman, MC Jensen
OncoImmunology 2015
Tolerance and efficacy of autologous or donor-derived T cells expressing CD19 chimeric antigen receptors in adult B-ALL with extramedullary leukemia
H Dai, W Zhang, X Li, Q Han, Y Guo, Y Zhang, Y Wang, C Wang, F Shi, Y Zhang, M Chen, K Feng, Q Wang, H Zhu, X Fu, S Li, W Han
OncoImmunology 2015
Early transduction produces highly functional chimeric antigen receptor-modified virus-specific T-cells with central memory markers: a Production Assistant for Cell Therapy (PACT) translational application
J Sun, LE Huye, N Lapteva, M Mamonkin, M Hiregange, B Ballard, O Dakhova, D Raghavan, AG Durett, SK Perna, B Omer, LA Rollins, AM Leen, JF Vera, G Dotti, AP Gee, MK Brenner, DG Myers, CM Rooney
Journal for ImmunoTherapy of Cancer 2015
Chimeric antigen receptors and bispecific antibodies to retarget T cells in pediatric oncology: CAR T Cells and BsAbs in Pediatric Oncology
M Suzuki, KJ Curran, NK Cheung
Pediatric Blood & Cancer 2015
Seatbelts in CAR therapy: How Safe Are CARS?
K Minagawa, X Zhou, S Mineishi, AD Stasi
Pharmaceuticals (Basel, Switzerland) 2015
Identification and selective expansion of functionally superior T cells expressing chimeric antigen receptors
ZN Chang, PA Silver, YY Chen
Journal of Translational Medicine 2015
Long-term Outcome of Extranodal NK/T Cell Lymphoma Patients Treated With Postremission Therapy Using EBV LMP1 and LMP2a-specific CTLs
SG Cho, N Kim, HJ Sohn, SK Lee, ST Oh, HJ Lee, HI Cho, HW Yim, SE Jung, G Park, JH Oh, BO Choi, SW Kim, SW Kim, NG Chung, JW Lee, YS Hong, TG Kim
Molecular Therapy 2015
CMVpp65 Vaccine Enhances the Antitumor Efficacy of Adoptively Transferred CD19-Redirected CMV-Specific T Cells
X Wang, CW Wong, R Urak, A Mardiros, LE Budde, WC Chang, SH Thomas, CE Brown, CL Rosa, DJ Diamond, MC Jensen, R Nakamura, JA Zaia, SJ Forman
Clinical cancer research 2015
Broad spectrum antiviral T cells for viral complications after hematopoietic stem cell transplantation
Britta Maecker-Kolhoff, Britta Eiz-Vesper
Annals of translational medicine 2015
The next step towards GMP-grade production of engineered immune cells
GJ Kierkels, T Straetemans, MA de Witte, J Kuball
OncoImmunology 2015
Smart CARs engineered for cancer immunotherapy:
SJ Priceman, SJ Forman, CE Brown
Current Opinion in Oncology 2015
T Cells Engineered against a Native Antigen Can Surmount Immunologic and Physical Barriers to Treat Pancreatic Ductal Adenocarcinoma
IM Stromnes, TM Schmitt, A Hulbert, JS Brockenbrough, HN Nguyen, C Cuevas, AM Dotson, X Tan, JL Hotes, PD Greenberg, SR Hingorani
Cancer Cell 2015
Chimeric Antigen Receptor T-Cells: New Approaches to Improve Their Efficacy and Reduce Toxicity
MV Maus, DJ Powell
The Cancer Journal 2015
Evaluation of Intracellular Signaling Downstream Chimeric Antigen Receptors
H Karlsson, E Svensson, C Gigg, M Jarvius, U Olsson-Strömberg, B Savoldo, G Dotti, A Loskog, K Tasken
PloS one 2015
New Strategies in Engineering T-cell Receptor Gene-Modified T cells to More Effectively Target Malignancies
TM Schmitt, IM Stromnes, AG Chapuis, PD Greenberg
Clinical cancer research 2015
Memory T Cells Specific for Murine Cytomegalovirus Re-Emerge after Multiple Challenges and Recapitulate Immunity in Various Adoptive Transfer Scenarios
M Quinn, H Turula, M Tandon, B Deslouches, T Moghbeli, CM Snyder
Journal of immunology (Baltimore, Md. : 1950) 2015
Chimeric Antigen Receptor Therapy for Cancer
DM Barrett, N Singh, DL Porter, SA Grupp, CH June
Annual Review of Medicine 2014
Engineering Human Peripheral Blood Stem Cell Grafts that Are Depleted of Naïve T Cells and Retain Functional Pathogen-Specific Memory T Cells
M Bleakley, S Heimfeld, LA Jones, C Turtle, D Krause, SR Riddell, W Shlomchik
Biology of Blood and Marrow Transplantation 2014
Advances in Experimental Medicine and Biology
C DeRenzo, S Gottschalk
Advances in experimental medicine and biology 2014
Promoting Thiol Expression Increases the Durability of Antitumor T-cell Functions
P Kesarwani, AA Al-Khami, G Scurti, K Thyagarajan, N Kaur, S Husain, Q Fang, OS Naga, P Simms, G Beeson, C Voelkel-Johnson, E Garrett-Mayer, CC Beeson, MI Nishimura, S Mehrotra
Cancer research 2014
Elimination of Progressive Mammary Cancer by Repeated Administrations of Chimeric Antigen Receptor-Modified T Cells
A Globerson-Levin, T Waks, Z Eshhar
Molecular Therapy 2014
Engineered T cells for cancer treatment
U Anurathapan, AM Leen, MK Brenner, JF Vera
Cytotherapy 2014
Manufacture of Gene-Modified Human T-Cells with a Memory Stem/Central Memory Phenotype
R Gomez-Eerland, B Nuijen, B Heemskerk, N Rooij, JH van Berg, JH Beijnen, W Uckert, P Kvistborg, TN Schumacher, JB Haanen, A Jorritsma
Human Gene Therapy Methods 2014
Relation of clinical culture method to T-cell memory status and efficacy in xenograft models of adoptive immunotherapy
DM Barrett, N Singh, X Liu, S Jiang, CH June, SA Grupp, Y Zhao
Cytotherapy 2014
Allogeneic lymphocyte-licensed DCs expand T cells with improved antitumor activity and resistance to oxidative stress and immunosuppressive factors
C Jin, D Yu, V Hillerdal, AC Wallgren, A Karlsson-Parra, M Essand
Molecular Therapy — Methods & Clinical Development 2014
Prostaglandin E2 promotes survival of naive UCB T cells via the Wnt/β-catenin pathway and alters immune reconstitution after UCBT
L Li, HT Kim, A Nellore, N Patsoukis, V Petkova, S McDonough, I Politikos, S Nikiforow, R Soiffer, JH Antin, K Ballen, C Cutler, J Ritz, VA Boussiotis
Blood Cancer Journal 2014
Cell-based strategies to manage leukemia relapse: efficacy and feasibility of immunotherapy approaches
A Rambaldi, E Biagi, C Bonini, A Biondi, M Introna
Leukemia 2014
Antigen-Specific Culture of Memory-like CD8 T Cells for Adoptive Immunotherapy
AJ Litterman, DM Zellmer, RS LaRue, SC Jameson, DA Largaespada
Cancer immunology research 2014
Immunologic special forces: anti-pathogen cytotoxic T-lymphocyte immunotherapy following hematopoietic stem cell transplantation
M Keller, C Bollard
ImmunoTargets and Therapy 2014
Adoptive Immunotherapy for Hematological Malignancies Using T Cells Gene-Modified to Express Tumor Antigen-Specific Receptors
H Fujiwara
Pharmaceuticals (Basel, Switzerland) 2014
Therapeutic targeting of naturally presented myeloperoxidase-derived HLA peptide ligands in myeloid leukemia cells by TCR-transgenic T cells
R Klar, S Schober, M Rami, S Mall, J Merl, SM Hauck, M Ueffing, A Admon, J Slotta-Huspenina, M Schwaiger, S Stevanović, RA Oostendorp, DH Busch, C Peschel, AM Krackhardt
Leukemia Supplements 2014
Progress and prospects for engineered T cell therapies
W Qasim, AJ Thrasher
British Journal of Haematology 2014
Adoptive Immunotherapy for Cancer or Viruses
MV Maus, JA Fraietta, BL Levine, M Kalos, Y Zhao, CH June
Annual Review of Immunology 2014
Closely related T-memory stem cells correlate with in vivo expansion of CAR.CD19-T cells and are preserved by IL-7 and IL-15
Y Xu, M Zhang, CA Ramos, A Durett, E Liu, O Dakhova, H Liu, CJ Creighton, AP Gee, HE Heslop, CM Rooney, B Savoldo, G Dotti
Blood 2014
Antigen-specific activation and cytokine-facilitated expansion of naive, human CD8+ T cells
M Wölfl, PD Greenberg
Nature Protocols 2014
Significance of interleukin-13 receptor alpha 2-targeted glioblastoma therapy
B Thaci, CE Brown, E Binello, K Werbaneth, P Sampath, S Sengupta
Neuro-Oncology 2014
A novel ex vivo isolation and expansion procedure for chimeric antigen receptor engrafted human T cells
M Cartellieri, S Koristka, C Arndt, A Feldmann, S Stamova, M Bonin, K Töpfer, T Krüger, M Geib, I Michalk, A Temme, M Bornhäuser, D Lindemann, G Ehninger, MP Bachmann
PloS one 2014
Homeostatic expansion as a barrier to lymphocyte depletion strategies:
NA Zwang, LA Turka
Current Opinion in Organ Transplantation 2014
The role of CD4+ T cells in BKV-specific T cell immunity
BJ Weist, M Schmueck, H Fuehrer, A Sattler, P Reinke, N Babel
Medical Microbiology and Immunology 2014
Anticancer Tc9 cells
Y Lu, Q Wang, Q Yi
OncoImmunology 2014
Chimeric antigen receptor for adoptive immunotherapy of cancer: latest research and future prospects
H Shi, M Sun, L Liu, Z Wang
Molecular Cancer 2014
Chimeric Antigen Receptors With Mutated IgG4 Fc Spacer Avoid Fc Receptor Binding and Improve T Cell Persistence and Antitumor Efficacy
M Jonnalagadda, A Mardiros, R Urak, X Wang, LJ Hoffman, A Bernanke, WC Chang, W Bretzlaff, R Starr, S Priceman, JR Ostberg, SJ Forman, CE Brown
Molecular Therapy 2014
Advances in T-cell therapy for ALL
SA Grupp
Best Practice & Research Clinical Haematology 2014
Adoptive Therapy With Chimeric Antigen Receptor–Modified T Cells of Defined Subset Composition:
SR Riddell, D Sommermeyer, C Berger, LS Liu, A Balakrishnan, A Salter, M Hudecek, DG Maloney, CJ Turtle
The Cancer Journal 2014
CD19-CAR Trials:
CA Ramos, B Savoldo, G Dotti
The Cancer Journal 2014
Metabolic Engineering of Salmonella Vaccine Bacteria To Boost Human V 2V 2 T Cell Immunity
G Workalemahu, H Wang, KJ Puan, MH Nada, T Kuzuyama, BD Jones, C Jin, CT Morita
Journal of immunology (Baltimore, Md. : 1950) 2014
Safety of Targeting ROR1 in Primates with Chimeric Antigen Receptor-Modified T Cells
C Berger, D Sommermeyer, M Hudecek, M Berger, A Balakrishnan, PJ Paszkiewicz, PL Kosasih, C Rader, SR Riddell
Cancer immunology research 2014
The Nonsignaling Extracellular Spacer Domain of Chimeric Antigen Receptors Is Decisive for In Vivo Antitumor Activity
M Hudecek, D Sommermeyer, PL Kosasih, A Silva-Benedict, L Liu, C Rader, MC Jensen, SR Riddell
Cancer immunology research 2014
Chemokines as Novel and Versatile Reagents for Flow Cytometry and Cell Sorting
ML le Brocq, AR Fraser, G Cotton, K Woznica, CV McCulloch, KD Hewit, CS McKimmie, RJ Nibbs, JD Campbell, GJ Graham
Journal of immunology (Baltimore, Md. : 1950) 2014
Nature Biotechnology's academic spinouts of 2013.
Bouchie A, Allison M, Webb S, DeFrancesco L
Nature Biotechnology 2014
A cytokine cocktail directly modulates the phenotype of DC-enriched anti-tumor T cells to convey potent anti-tumor activities in a murine model
S Yang, GE Archer, CE Flores, DA Mitchell, JH Sampson
Cancer Immunology, Immunotherapy 2013
Uncoupling T-cell expansion from effector differentiation in cell-based immunotherapy
JG Crompton, M Sukumar, NP Restifo
Immunological Reviews 2013
Impact of T cell selection methods in the success of clinical adoptive immunotherapy
N Ramírez, L Beloki, M Ciaúrriz, M Rodríguez-Calvillo, D Escors, C Mansilla, E Bandrés, E Olavarría
Cellular and Molecular Life Sciences 2013
Re-adapting T cells for cancer therapy: from mouse models to clinical trials
IM Stromnes, TM Schmitt, AG Chapuis, SR Hingorani, PD Greenberg
Immunological Reviews 2013
Potential limitations of the NSG humanised mouse as a model system to optimise engineered human T cell therapy for cancer
EM Alcantar-Orozco, H Gornall, V Baldan, RE Hawkins, DE Gilham
Human Gene Therapy Methods 2013
Clinical-scale selection and viral transduction of human naïve and central memory CD8+ T cells for adoptive cell therapy of cancer patients
A Casati, A Varghaei-Nahvi, SA Feldman, M Assenmacher, SA Rosenberg, ME Dudley, A Scheffold
Cancer Immunology, Immunotherapy 2013
A practical approach to immunotherapy of hepatocellular carcinoma using T cells redirected against hepatitis B virus
S Koh, N Shimasaki, R Suwanarusk, ZZ Ho, A Chia, N Banu, SW Howland, AS Ong, AJ Gehring, H Stauss, L Renia, M Sällberg, D Campana, A Bertoletti
Molecular Therapy — Nucleic Acids 2013
Hematopoietic stem cells for cancer immunotherapy
E Gschweng, SD Oliveira, DB Kohn
Immunological Reviews 2013
Human cell-based artificial antigen-presenting cells for cancer immunotherapy
MO Butler, N Hirano
Immunological Reviews 2013
Chimeric antigen receptors (CARs) from bench-to-bedside
B Savoldo, G Dotti
Immunology Letters 2013
Rapamycin-resistant effector T-cell therapy
DH Fowler
Immunological Reviews 2013
Proliferation-linked apoptosis of adoptively transferred T cells after IL-15 administration in macaques
C Berger, M Berger, BC Beard, HP Kiem, TA Gooley, SR Riddell
PloS one 2013
Exploiting the curative potential of adoptive T-cell therapy for cancer
CS Hinrichs, SA Rosenberg
Immunological Reviews 2013
Efficient selection of genetically modified human T cells using methotrexate-resistant human dihydrofolate reductase
M Jonnalagadda, CE Brown, WC Chang, JR Ostberg, SJ Forman, MC Jensen
Gene Therapy 2013
Transferred WT1-Reactive CD8+ T Cells Can Mediate Antileukemic Activity and Persist in Post-Transplant Patients
AG Chapuis, GB Ragnarsson, HN Nguyen, CN Chaney, JS Pufnock, TM Schmitt, N Duerkopp, IM Roberts, GL Pogosov, WY Ho, S Ochsenreither, M Wolfl, M Bar, JP Radich, C Yee, PD Greenberg
Science Translational Medicine 2013
Allelic Exclusion and Peripheral Reconstitution by TCR Transgenic T Cells Arising From Transduced Human Hematopoietic Stem/Progenitor Cells
F Giannoni, CL Hardee, J Wherley, E Gschweng, S Senadheera, ML Kaufman, R Chan, I Bahner, V Gersuk, X Wang, D Gjertson, D Baltimore, ON Witte, JS Economou, A Ribas, DB Kohn
Molecular Therapy 2013
Genetically engineered T cells for the treatment of cancer
M Essand, AS Loskog
Journal of Internal Medicine 2013
Adoptive T Cell Transfer for Cancer Immunotherapy in the Era of Synthetic Biology
M Kalos, CH June
Immunity 2013
CD4 T-cell immunotherapy for chronic viral infections and cancer
AO Kamphorst, R Ahmed
Immunotherapy 2013
T cells expressing CD123-specific chimeric antigen receptors exhibit specific cytolytic effector functions and antitumor effects against human acute myeloid leukemia
A Mardiros, CD Santos, T McDonald, CE Brown, X Wang, LE Budde, L Hoffman, B Aguilar, WC Chang, W Bretzlaff, B Chang, M Jonnalagadda, R Starr, JR Ostberg, MC Jensen, R Bhatia, SJ Forman
Blood 2013
TCR-Engineered T Cells Meet New Challenges to Treat Solid Tumors: Choice of Antigen, T Cell Fitness, and Sensitization of Tumor Milieu
A Kunert, T Straetemans, C Govers, C Lamers, R Mathijssen, S Sleijfer, R Debets
Frontiers in immunology 2013
T-cell therapies for HIV
S Lam, C Bollard
Immunotherapy 2013
Adoptive T-cell therapy for hematological malignancies using T cells gene-modified to express tumor antigen-specific receptors
H Fujiwara
International Journal of Hematology 2013
Chimeric antigen receptor modified T cell therapy for B cell malignancies
CJ Turtle
International Journal of Hematology 2013
Design and implementation of adoptive therapy with chimeric antigen receptor-modified T cells
MC Jensen, SR Riddell
Immunological Reviews 2013
Genetically modified T cells for the treatment of malignant disease
A Wieczorek, L Uharek
Transfusion Medicine and Hemotherapy 2013
Genetically modified T cells to target glioblastoma
S Krebs, TG Rodríguez-Cruz, C Derenzo, S Gottschalk
Frontiers in Oncology 2013
Combining a CD20 chimeric antigen receptor and an inducible caspase 9 suicide switch to improve the efficacy and safety of T cell adoptive immunotherapy for lymphoma
LE Budde, C Berger, Y Lin, J Wang, X Lin, SE Frayo, SA Brouns, DM Spencer, BG Till, MC Jensen, SR Riddell, OW Press
PloS one 2013
Chimeric antigen receptor-engineered T cells for cancer immunotherapy: progress and challenges
EQ Han, X Li, C Wang, T Li, S Han
Journal of Hematology & Oncology 2013
Engineering human T cells for resistance to methotrexate and mycophenolate mofetil as an in vivo cell selection strategy
M Jonnalagadda, CE Brown, WC Chang, JR Ostberg, SJ Forman, MC Jensen
PloS one 2013
Sleeping beauty system to redirect T-cell specificity for human applications
SN Maiti, H Huls, H Singh, M Dawson, M Figliola, S Olivares, P Rao, YJ Zhao, A Multani, G Yang, L Zhang, D Crossland, S Ang, H Torikai, B Rabinovich, DA Lee, P Kebriaei, P Hackett, RE Champlin, LJ Cooper
Journal of immunotherapy (Hagerstown, Md. : 1997) 2013
Adoptive T-cell immunotherapy from third-party donors: characterization of donors and set up of a T-cell donor registry
B Eiz-Vesper, B Maecker-Kolhoff, R Blasczyk
Frontiers in immunology 2013
Regression of Metastatic Merkel Cell Carcinoma Following Transfer of Polyomavirus-Specific T Cells and Therapies Capable of Reinducing HLA Class-I
AG Chapuis, OK Afanasiev, JG Iyer, KG Paulson, U Parvathaneni, JH Hwang, I Lai, IM Roberts, HL Sloan, S Bhatia, KC Shibuya, T Gooley, C Desmarais, DM Koelle, C Yee, P Nghiem
Cancer immunology research 2013
Sustained Complete Responses in Patients With Lymphoma Receiving Autologous Cytotoxic T Lymphocytes Targeting Epstein-Barr Virus Latent Membrane Proteins
CM Bollard, S Gottschalk, V Torrano, O Diouf, S Ku, Y Hazrat, G Carrum, C Ramos, L Fayad, EJ Shpall, B Pro, H Liu, MF Wu, D Lee, AM Sheehan, Y Zu, AP Gee, MK Brenner, HE Heslop, CM Rooney
Journal of Clinical Oncology 2013
Understanding the biology of ex vivo-expanded CD8 T cells for adoptive cell therapy: role of CD62L.
Díaz-Montero CM, Zidan AA, Pallin MF, Anagnostopoulos V, Salem ML, Wieder E, Komanduri K, Montero AJ, Lichtenheld MG
Immunologic research 2013
The stoichiometric production of IL-2 and IFN-γ mRNA defines memory T cells that can self-renew after adoptive transfer in humans
A Wang, S Chandran, SA Shah, Y Chiu, BC Paria, T Aghamolla, MM Alvarez-Downing, CC Lee, S Singh, T Li, ME Dudley, NP Restifo, SA Rosenberg, US Kammula
Science Translational Medicine 2012
Novel Serial Positive Enrichment Technology Enables Clinical Multiparameter Cell Sorting
C Stemberger, S Dreher, C Tschulik, C Piossek, J Bet, TN Yamamoto, M Schiemann, M Neuenhahn, K Martin, M Schlapschy, A Skerra, T Schmidt, M Edinger, SR Riddell, L Germeroth, DH Busch
PloS one 2012
Gene Therapy-Mediated Reprogramming Tumor Infiltrating T Cells Using IL-2 and Inhibiting NF-κB Signaling Improves the Efficacy of Immunotherapy in a Brain Cancer Model
Y Mineharu, AK Muhammad, K Yagiz, M Candolfi, KM Kroeger, W Xiong, M Puntel, C Liu, E Levy, C Lugo, A Kocharian, JP Allison, MA Curran, PR Lowenstein, MG Castro
Neurotherapeutics 2012
Lessons in Nonhuman Primate Models for AIDS Vaccine Research: From Minefields to Milestones
JD Lifson, NL Haigwood
Cold Spring Harbor Perspectives in Medicine 2012
Editing T cell specificity towards leukemia by zinc finger nucleases and lentiviral gene transfer
E Provasi, P Genovese, A Lombardo, Z Magnani, PQ Liu, A Reik, V Chu, DE Paschon, L Zhang, J Kuball, B Camisa, A Bondanza, G Casorati, M Ponzoni, F Ciceri, C Bordignon, PD Greenberg, MC Holmes, PD Gregory, L Naldini, C Bonini
Nature Medicine 2012
Paths to stemness: building the ultimate antitumour T cell
L Gattinoni, CA Klebanoff, NP Restifo
Nature Reviews Cancer 2012
The Past, Present, and Future of Adoptive T Cell Therapy
D Choi, TG Kim, YC Sung
Immune Network 2012
Augmentation of anti-tumor immunity by adoptive T-cell transfer after allogeneic hematopoietic stem cell transplantation
M Bleakley, CJ Turtle, SR Riddell
Expert Review of Hematology 2012
Improving TCR Gene Therapy for Treatment of Haematological Malignancies
E Nicholson, S Ghorashian, H Stauss
Advances in Hematology 2012
Stimulation of Wnt/ß-Catenin Pathway in Human CD8+ T Lymphocytes from Blood and Lung Tumors Leads to a Shared Young/Memory Phenotype
MA Forget, Y Huon, A Reuben, C Grange, M Liberman, J Martin, AM Mes-Masson, N Arbour, R Lapointe
PloS one 2012
How (specific) would you like your T-cells today? Generating T-cell therapeutic function through TCR-gene transfer
I Daniel-Meshulam, S Ya'akobi, C Ankri, CJ Cohen
Frontiers in immunology 2012
Current translational and clinical practices in hematopoietic cell and gene therapy
DL Digiusto, HP Kiem
Cytotherapy 2012
Modulating the differentiation status of ex vivo-cultured anti-tumor T cells using cytokine cocktails
S Yang, Y Ji, L Gattinoni, L Zhang, Z Yu, NP Restifo, SA Rosenberg, RA Morgan
Cancer Immunology, Immunotherapy 2012
A combination of local inflammation and central memory T cells potentiates immunotherapy in the skin
S Fiorenza, TJ Kenna, I Comerford, S McColl, RJ Steptoe, GR Leggatt, IH Frazer
Journal of immunology (Baltimore, Md. : 1950) 2012
Phenotypic and functional attributes of lentivirus-modified CD19-specific human CD8+ central memory T cells manufactured at clinical scale
X Wang, A Naranjo, CE Brown, C Bautista, CW Wong, WC Chang, B Aguilar, JR Ostberg, SR Riddell, SJ Forman, MC Jensen
Journal of immunotherapy (Hagerstown, Md. : 1997) 2012
Sorting through subsets: which T-cell populations mediate highly effective adoptive immunotherapy?
CA Klebanoff, L Gattinoni, NP Restifo
Journal of immunotherapy (Hagerstown, Md. : 1997) 2012
Ex vivo interleukin-12-priming during CD8(+) T cell activation dramatically improves adoptive T cell transfer antitumor efficacy in a lymphodepleted host
MP Rubinstein, CA Cloud, TE Garrett, CJ Moore, KM Schwartz, CB Johnson, DH Craig, ML Salem, CM Paulos, DJ Cole
Journal of the American College of Surgeons 2012
The Future Is Now: Chimeric Antigen Receptors as New Targeted Therapies for Childhood Cancer
DW Lee, DM Barrett, C Mackall, R Orentas, SA Grupp
Clinical cancer research 2012
Adoptive immunotherapy for cancer: harnessing the T cell response
NP Restifo, ME Dudley, SA Rosenberg
Nature Reviews Immunology 2012
Investigative and clinical applications of synthetic immune synapses
MC Milone, LC Kam
Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology 2012
Chimeric antigen receptor--modified T cells: clinical translation in stem cell transplantation and beyond
SR Riddell, MC Jensen, CH June
Biology of Blood and Marrow Transplantation 2012
Transferred melanoma-specific CD8+ T cells persist, mediate tumor regression, and acquire central memory phenotype
AG Chapuis, JA Thompson, KA Margolin, R Rodmyre, IP Lai, K Dowdy, EA Farrar, S Bhatia, DE Sabath, J Cao, Y Li, C Yee
Proceedings of the National Academy of Sciences 2012
Generation and administration of HA-1-specific T-cell lines for the treatment of patients with relapsed leukemia after allogeneic stem cell transplantation: a pilot study
P Meij, I Jedema, MA van der Hoorn, R Bongaerts, L Cox, AR Wafelman, EW Marijt, R Willemze, JH Falkenburg
Haematologica 2012
Harnessing Autophagy for Adoptive T Cell Therapy
S Amarnath, DH Fowler
Immunotherapy 2012
Immunological milieu in the peritoneal cavity at laparotomy for gastric cancer
A Yoneda, S Ito, S Susumu, M Matsuo, K Taniguchi, Y Tajima, S Eguchi, T Kanematsu, Y Nagata
World journal of gastroenterology : WJG 2012
New directions in cellular therapy of cancer: a summary of the summit on cellular therapy for cancer
DF Stroncek, C Berger, MA Cheever, RW Childs, ME Dudley, P Flynn, L Gattinoni, JR Heath, M Kalos, FM Marincola, JS Miller, G Mostoslavsky, DJ Powell, M Rao, NP Restifo, SA Rosenberg, J O'Shea, CJ Melief
Journal of Translational Medicine 2012
Tumor-Infiltrating Lymphocytes in Melanoma
S Lee, K Margolin
Current Oncology Reports 2012
Engineered T cells for anti-cancer therapy
CJ Turtle, M Hudecek, MC Jensen, SR Riddell
Current Opinion in Immunology 2012
Graft-versus-leukemia Effect of HLA-haploidentical Central-memory T-cells Expanded With Leukemic APCs and Modified With a Suicide Gene
M Casucci, SK Perna, L Falcone, B Camisa, Z Magnani, M Bernardi, A Crotta, C Tresoldi, K Fleischhauer, M Ponzoni, S Gregori, FC Cappio, F Ciceri, C Bordignon, A Cignetti, A Bondanza, C Bonini
Molecular Therapy 2012
Chimeric antigen receptors for T cell immunotherapy: current understanding and future directions: CARs for T cell Immunotherapy
KJ Curran, HJ Pegram, RJ Brentjens
The Journal of Gene Medicine 2012
Stem-like tumor-initiating cells isolated from IL13Rα2 expressing gliomas are targeted and killed by IL13-zetakine-redirected T Cells
CE Brown, R Starr, B Aguilar, AF Shami, C Martinez, M D'Apuzzo, ME Barish, SJ Forman, MC Jensen
Clinical cancer research 2012
Agonistic antibody to CD40 boosts the antitumor activity of adoptively transferred T cells in vivo
C Liu, CM Lewis, Y Lou, C Xu, W Peng, Y Yang, AH Gelbard, G Lizée, D Zhou, WW Overwijk, P Hwu
Journal of immunotherapy (Hagerstown, Md. : 1997) 2012
Moving Successful Virus-specific T-cell Therapy for Hematopoietic Stem Cell Recipients to Late Phase Clinical Trials
C Rooney, A Leen
Molecular Therapy — Nucleic Acids 2012
Loss of antigen cross-presentation after complete tumor resection is associated with the generation of protective tumor-specific CD8(+) T-cell immunity
MD Brown, R der Most, JB Vivian, RA Lake, I Larma, BW Robinson, AJ Currie
OncoImmunology 2012
Lenalidomide-induced immunomodulation in multiple myeloma: impact on vaccines and antitumor responses
K Noonan, L Rudraraju, A Ferguson, A Emerling, MF Pasetti, CA Huff, I Borrello
Clinical cancer research 2012
Immunology in the clinic review series; focus on cancer: double trouble for tumours: bi-functional and redirected T cells as effective cancer immunotherapies
LA Marr, DE Gilham, JD Campbell, AR Fraser
Clinical & Experimental Immunology 2012
CARs: Driving T-cell specificity to enhance anti-tumor immunity
Kebriaei P, Kelly SS, Manuri P, Jena B, Jackson R, Shpall E, Champlin R, Cooper LJ
Frontiers in bioscience (Scholar edition) 2012
Neuroantigen-Specific CD8+ Regulatory T-Cell Function is Deficient During Acute Exacerbation of Multiple Sclerosis
EJ Baughman, JP Mendoza, SB Ortega, CL Ayers, BM Greenberg, EM Frohman, NJ Karandikar
Journal of Autoimmunity 2011
Antitumor activity and long-term fate of chimeric antigen receptor–positive T cells in patients with neuroblastoma
CU Louis, B Savoldo, G Dotti, M Pule, E Yvon, GD Myers, C Rossig, HV Russell, O Diouf, E Liu, H Liu, MF Wu, AP Gee, Z Mei, CM Rooney, HE Heslop, MK Brenner
Blood 2011
HIV-specific CD8+ T cells from HIV+ individuals receiving HAART can be expanded ex vivo to augment systemic and mucosal immunity in vivo
AG Chapuis, C Casper, S Kuntz, J Zhu, A Tjernlund, K Diem, CJ Turtle, ML Cigal, R Velez, S Riddell, L Corey, PD Greenberg
Blood 2011
Buffered memory: a hypothesis for the maintenance of functional, virus-specific CD8+ T cells during cytomegalovirus infection
CM Snyder
Immunologic Research 2011
Human effector CD8+ T cells derived from naive rather than memory subsets possess superior traits for adoptive immunotherapy
CS Hinrichs, ZA Borman, L Gattinoni, Z Yu, WR Burns, J Huang, CA Klebanoff, LA Johnson, SP Kerkar, S Yang, P Muranski, DC Palmer, CD Scott, RA Morgan, PF Robbins, SA Rosenberg, NP Restifo
Blood 2011
Ex vivo gene transfer and correction for cell-based therapies
L Naldini
Nature Reviews Genetics 2011
Engineered T cells for the adoptive therapy of B-cell chronic lymphocytic leukaemia
P Koehler, P Schmidt, AA Hombach, M Hallek, H Abken
Advances in Hematology 2011
Chimeric Antigen Receptor (CAR)-Engineered Lymphocytes for Cancer Therapy
CA Ramos, G Dotti
Expert Opinion on Biological Therapy 2011
In vitro generated anti-tumor T lymphocytes exhibit distinct subsets mimicking in vivo antigen-experienced cells
S Yang, L Gattinoni, G Luca, F Liu, Y Ji, Z Yu, NP Restifo, SA Rosenberg, RA Morgan
Cancer Immunology, Immunotherapy 2011
The Shedding of CD62L (L-Selectin) Regulates the Acquisition of Lytic Activity in Human Tumor Reactive T Lymphocytes
S Yang, F Liu, QJ Wang, SA Rosenberg, RA Morgan
PloS one 2011
Th17 Cells Are Long Lived and Retain a Stem Cell-like Molecular Signature
P Muranski, ZA Borman, SP Kerkar, CA Klebanoff, Y Ji, L Sanchez-Perez, M Sukumar, RN Reger, Z Yu, SJ Kern, R Roychoudhuri, GA Ferreyra, W Shen, SK Durum, L Feigenbaum, DC Palmer, PA Antony, CC Chan, A Laurence, RL Danner, L Gattinoni, NP Restifo
Immunity 2011
Priming CD8+ T cells with dendritic cells matured using TLR4 and TLR7/8 ligands together enhances generation of CD8+ T cells retaining CD28
JS Pufnock, M Cigal, LS Rolczynski, E Andersen-Nissen, M Wolfl, MJ McElrath, PD Greenberg
Blood 2011
Activation of Wnt signaling arrests effector differentiation in human peripheral and cord blood-derived T lymphocytes
S Muralidharan, PJ Hanley, E Liu, R Chakraborty, C Bollard, E Shpall, C Rooney, B Savoldo, J Rodgers, G Dotti
Journal of immunology (Baltimore, Md. : 1950) 2011
Exploiting T cells specific for human minor histocompatibility antigens for therapy of leukemia
M Bleakley, SR Riddell
Immunology and Cell Biology 2011
Immune Reconstitution in Recipients of Photodepleted HLA-Identical Sibling Donor Stem Cell Transplantations: T Cell Subset Frequencies Predict Outcome
ZA McIver, JJ Melenhorst, A Grim, N Naguib, G Weber, V Fellowes, H Khuu, DS Stroncek, SF Leitman, M Battiwalla, AJ Barrett
Biology of Blood and Marrow Transplantation 2011
CARs on Track in the Clinic
DB Kohn, G Dotti, R Brentjens, B Savoldo, M Jensen, LJ Cooper, CH June, S Rosenberg, M Sadelain, HE Heslop
Molecular Therapy 2011
Establishment of Antitumor Memory in Humans Using in Vitro-Educated CD8+ T Cells
MO Butler, P Friedlander, MI Milstein, MM Mooney, G Metzler, AP Murray, M Tanaka, A Berezovskaya, O Imataki, L Drury, L Brennan, M Flavin, D Neuberg, K Stevenson, D Lawrence, FS Hodi, EF Velazquez, MT Jaklitsch, SE Russell, M Mihm, LM Nadler, N Hirano
Science Translational Medicine 2011
Specific recognition and inhibition of Ewing tumour growth by antigen-specific allo-restricted cytotoxic T cells
U Thiel, S Pirson, C Müller-Spahn, H Conrad, DH Busch, H Bernhard, S Burdach, GH Richter
British Journal of Cancer 2011
Retinoic acid and rapamycin differentially affect and synergistically promote the ex vivo expansion of natural human T regulatory cells
TN Golovina, T Mikheeva, TM Brusko, BR Blazar, JA Bluestone, JL Riley
PloS one 2011
Biomarkers in T cell therapy clinical trials
M Kalos
Journal of Translational Medicine 2011
Generation of CD19-chimeric antigen receptor modified CD8+ T cells derived from virus-specific central memory T cells
S Terakura, TN Yamamoto, RA Gardner, CJ Turtle, MC Jensen, SR Riddell
Blood 2011
Genetically retargeting CD8+ lymphocyte subsets for cancer immunotherapy
CJ Turtle, SR Riddell
Current Opinion in Immunology 2011
Genetic Modification of T Cells
C Bonini, MK Brenner, HE Heslop, RA Morgan
Biology of Blood and Marrow Transplantation 2011
Engraftment of human central memory-derived effector CD8+ T cells in immunodeficient mice
X Wang, C Berger, CL Wong, SJ Forman, SR Riddell, MC Jensen
Blood 2011
Rapid detection, enrichment and propagation of specific T cell subsets based on cytokine secretion
JD Campbell, A Foerster, V Lasmanowicz, M Niemöller, A Scheffold, M Fahrendorff, G Rauser, M Assenmacher, A Richter
Clinical & Experimental Immunology 2011
PD-L1 blockade effectively restores strong graft-versus-leukemia effects without graft-versus-host disease after delayed adoptive transfer of T-cell receptor gene-engineered allogeneic CD8+ T cells
W Koestner, M Hapke, J Herbst, C Klein, K Welte, J Fruehauf, A Flatley, DA Vignali, M Hardtke-Wolenski, E Jaeckel, BR Blazar, MG Sauer
Blood 2011
Activated NKT Cells and NK Cells Render T Cells Resistant to Myeloid-Derived Suppressor Cells and Result in an Effective Adoptive Cellular Therapy against Breast Cancer in the FVBN202 Transgenic Mouse
M Kmieciak, D Basu, KK Payne, A Toor, A Yacoub, XY Wang, L Smith, HD Bear, MH Manjili
Journal of immunology (Baltimore, Md. : 1950) 2011
Muscle CARs and TcRs: turbo-charged technologies for the (T cell) masses
Kalos M
Cancer Immunology, Immunotherapy 2011
Graft-versus-leukemia antigen CML66 elicits coordinated B-cell and T-cell immunity after donor lymphocyte infusion
W Zhang, J Choi, W Zeng, SA Rogers, EP Alyea, JG Rheinwald, CM Canning, V Brusic, T Sasada, EL Reinherz, J Ritz, RJ Soiffer, CJ Wu
Clinical cancer research 2010
IL-7 and IL-21 are superior to IL-2 and IL-15 in promoting human T cell-mediated rejection of systemic lymphoma in immunodeficient mice
JC Markley, M Sadelain
Blood 2010
Evaluating the cellular targets of anti-4-1BB agonist antibody during immunotherapy of a pre-established tumor in mice
GH Lin, Y Liu, T Ambagala, BS Kwon, PS Ohashi, TH Watts
PloS one 2010
Adoptive cell therapy of prostate cancer using female mice-derived T cells that react with prostate antigens
H Yi, X Yu, C Guo, MH Manjili, EA Repasky, XY Wang
Cancer Immunology, Immunotherapy 2010
NCI First International Workshop on The Biology, Prevention, and Treatment of Relapse After Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on the Biology Underlying Recurrence of Malignant Disease following Allogeneic HSCT: Graft-versus-Tumor/Leukemia Reaction
JS Miller, EH Warren, MR van Brink, J Ritz, WD Shlomchik, WJ Murphy, AJ Barrett, HJ Kolb, S Giralt, MR Bishop, BR Blazar, JH Falkenburg
Biology of Blood and Marrow Transplantation 2010
NCI First International Workshop on the Biology, Prevention and Treatment of Relapse after Allogeneic Hematopoietic Cell Transplantation: Report from the Committee on Prevention of Relapse Following Allogeneic Cell Transplantation for Hematological Malignancies
EP Alyea, DJ DeAngelo, J Moldrem, JM Pagel, D Przepiorka, M Sadelin, JW Young, S Giralt, M Bishop, S Riddell
Biology of Blood and Marrow Transplantation 2010
Chimeric Antigen Receptor-Engineered T Cells for Immunotherapy of Cancer
M Cartellieri, M Bachmann, A Feldmann, C Bippes, S Stamova, R Wehner, A Temme, M Schmitz
Journal of Biomedicine and Biotechnology 2010
Adoptive transfer of unselected or leukemia-reactive T-cells in the treatment of relapse following allogeneic hematopoietic cell transplantation
RJ O’Reilly, T Dao, G Koehne, D Scheinberg, E Doubrovina
Seminars in Immunology 2010
The B-cell tumor–associated antigen ROR1 can be targeted with T cells modified to express a ROR1-specific chimeric antigen receptor
M Hudecek, TM Schmitt, S Baskar, MT Lupo-Stanghellini, T Nishida, TN Yamamoto, M Bleakley, CJ Turtle, WC Chang, HA Greisman, B Wood, DG Maloney, MC Jensen, C Rader, SR Riddell
Blood 2010
The impact of ex vivo clinical grade activation protocols on human T cell phenotype and function for the generation of genetically modified cells for adoptive cell transfer therapy
PC Tumeh, RC Koya, T Chodon, NA Graham, TG Graeber, B Comin-Anduix, A Ribas
Journal of immunotherapy (Hagerstown, Md. : 1997) 2010
Prevention of Interleukin-2 Withdrawal-Induced Apoptosis in Lymphocytes Retrovirally Cotransduced With Genes Encoding an Antitumor T-cell Receptor and an Antiapoptotic Protein:
A Kalbasi, RK Shrimali, D Chinnasamy, SA Rosenberg
Journal of immunotherapy (Hagerstown, Md. : 1997) 2010
A Simplified Method for the Clinical-scale Generation of Central Memory-like CD8+ T Cells After Transduction With Lentiviral Vectors Encoding Antitumor Antigen T-cell Receptors
S Yang, ME Dudley, SA Rosenberg, RA Morgan
Journal of immunotherapy (Hagerstown, Md. : 1997) 2010
Redirecting T-cell specificity by introducing a tumor-specific chimeric antigen receptor
B Jena, G Dotti, LJ Cooper
Blood 2010
Artificial Antigen-Presenting Cells for Use in Adoptive Immunotherapy
CJ Turtle, SR Riddell
The Cancer Journal 2010
Application of Adoptive T-Cell Therapy Using Tumor Antigen-Specific T-Cell Receptor Gene Transfer for the Treatment of Human Leukemia
T Ochi, H Fujiwara, M Yasukawa
Journal of Biomedicine and Biotechnology 2010
Targeting Stat3 in the myeloid compartment drastically improves the in vivo antitumor functions of adoptively transferred T cells
A Herrmann, M Kortylewski, M Kujawski, C Zhang, K Reckamp, B Armstrong, L Wang, C Kowolik, J Deng, R Figlin, H Yu
Cancer research 2010
Genetic control of mammalian T-cell proliferation with synthetic RNA regulatory systems
YY Chen, MC Jensen, CD Smolke
Proceedings of the National Academy of Sciences 2010
A Transposon and Transposase System for Human Application
PB Hackett, DA Largaespada, LJ Cooper
Molecular Therapy 2010
Rebalancing Immune Specificity and Function in Cancer by T-Cell Receptor Gene Therapy
A Udyavar, TL Geiger
Archivum Immunologiae et Therapiae Experimentalis 2010
Accelerated Production of Antigen-specific T Cells for Preclinical and Clinical Applications Using Gas-permeable Rapid Expansion Cultureware (G-Rex)
JF Vera, LJ Brenner, U Gerdemann, MC Ngo, U Sili, H Liu, J Wilson, G Dotti, HE Heslop, AM Leen, CM Rooney
Journal of Immunotherapy 2010
JAK3/STAT5/6 Pathway Alterations Are Associated with Immune Deviation in CD8+ T Cells in Renal Cell Carcinoma Patients
E Cavalcanti, M Gigante, V Mancini, M Battaglia, P Ditonno, C Capobianco, RI Cincione, FP Selvaggi, W Herr, WJ Storkus, L Gesualdo, E Ranieri
Journal of Biomedicine and Biotechnology 2010
Therapy of relapsed leukemia after allogeneic hematopoietic cell transplantation with T cells specific for minor histocompatibility antigens
EH Warren, N Fujii, Y Akatsuka, CN Chaney, JK Mito, KR Loeb, TA Gooley, ML Brown, KK Koo, KV Rosinski, S Ogawa, A Matsubara, FR Appelbaum, SR Riddell
Blood 2010
Translating Sleeping Beauty transposition into cellular therapies: Victories and challenges
Z Izsvák, PB Hackett, LJ Cooper, Z Ivics
BioEssays 2010
piggyBacTransposon/Transposase System to Generate CD19-Specific T Cells for the Treatment of B-Lineage Malignancies
PV Manuri, MH Wilson, SN Maiti, T Mi, H Singh, S Olivares, MJ Dawson, H Huls, DA Lee, PH Rao, JM Kaminski, Y Nakazawa, S Gottschalk, P Kebriaei, EJ Shpall, RE Champlin, LJ Cooper
Human Gene Therapy 2010
Redirecting the Immune Response: Role of Adoptive T Cell Therapy
A Mondino, V Dardalhon, RH Michelini, S Loisel-Meyer, N Taylor
Human Gene Therapy 2010
PD-1 expression on peripheral CD8+ TEM/TEMRA subsets closely correlated with HCV viral load in chronic hepatitis C patients
T Shen, J Zheng, C Xu, J Liu, W Zhang, F Lu, H Zhuang
Virology Journal 2010
Exhaustive expansion: A novel technique for analyzing complex data generated by higher-order polychromatic flow cytometry experiments
JC Siebert, L Wang, DP Haley, A Romer, B Zheng, W Munsil, KW Gregory, EB Walker
Journal of Translational Medicine 2010
Combined CD8+ and CD4+ adenovirus hexon-specific T cells associated with viral clearance after stem cell transplantation as treatment for adenovirus infection
ML Zandvliet, JH Falkenburg, E Liempt, LA Veltrop-Duits, AC Lankester, JS Kalpoe, MG Kester, DM van der Steen, MJ van Tol, R Willemze, HJ Guchelaar, MW Schilham, P Meij
Haematologica 2010
Combining CD19 redirection and alloanergization to generate tumor-specific human T cells for allogeneic cell therapy of B-cell malignancies
JK Davies, H Singh, H Huls, D Yuk, DA Lee, P Kebriaei, RE Champlin, LM Nadler, EC Guinan, LJ Cooper
Cancer research 2010
Adoptive T cell therapy of cancer
MK Brenner, HE Heslop
Current Opinion in Immunology 2010
Challenges of T cell therapies for virus-associated diseases after hematopoietic stem cell transplantation
AM Leen, T Tripic, CM Rooney
Expert Opinion on Biological Therapy 2010
A nonhuman primate model for analysis of safety, persistence and function of adoptively transferred T cells
C Berger, M Berger, D Anderson, SR Riddell
Journal of Medical Primatology 2010
Anti-Transgene Rejection Responses Contribute to Attenuated Persistence of Adoptively Transferred CD20/CD19-Specific Chimeric Antigen Receptor Re-directed T Cells in Humans
MC Jensen, L Popplewell, LJ Cooper, D DiGiusto, M Kalos, JR Ostberg, SJ Forman
Biology of Blood and Marrow Transplantation 2010
Tumor-Primed, In Vitro-Activated CD4 + Effector T Cells Establish Long-Term Memory without Exogenous Cytokine Support or Ongoing Antigen Exposure
LX Wang, GE Plautz
Journal of immunology (Baltimore, Md. : 1950) 2010
Mantle cell lymphoma: report of the 2010 Mantle Cell Lymphoma Consortium Workshop.
Williams ME, Connors JM, Dreyling MH, Gascoyne RD, Kahl BS, Leonard JP, Press OW, Wilson WH
Leukemia & Lymphoma 2010
IL-21-treated naive CD45RA+ CD8+ T cells represent a reliable source for producing leukemia-reactive cytotoxic T lymphocytes with high proliferative potential and early differentiation phenotype
Albrecht J, Frey M, Teschner D, Carbol A, Theobald M, Herr W, Distler E
Cancer Immunology, Immunotherapy 2010
Self-antigen-specific CD8+ T cell precursor frequency determines the quality of the antitumor immune response
GA Rizzuto, T Merghoub, D Hirschhorn-Cymerman, C Liu, AM Lesokhin, D Sahawneh, H Zhong, KS Panageas, MA Perales, G Altan-Bonnet, JD Wolchok, AN Houghton
Journal of Experimental Medicine 2009
A panel of artificial APCs expressing prevalent HLA alleles permits generation of cytotoxic T cells specific for both dominant and subdominant viral epitopes for adoptive therapy
AN Hasan, WJ Kollen, D Trivedi, A Selvakumar, B Dupont, M Sadelain, RJ O'Reilly
Journal of immunology (Baltimore, Md. : 1950) 2009
Harnessing the physiology of lymphopenia to support adoptive immunotherapy in lymphoreplete hosts
Y Cui, H Zhang, J Meadors, R Poon, M Guimond, CL Mackall
Blood 2009
The transfer of adaptive immunity to CMV during hematopoietic stem cell transplantation is dependent on the specificity and phenotype of CMV-specific T cells in the donor
P Scheinberg, JJ Melenhorst, JM Brenchley, BJ Hill, NF Hensel, PK Chattopadhyay, M Roederer, LJ Picker, DA Price, AJ Barrett, DC Douek
Blood 2009
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 2009
Treatment of lymphoma with adoptively transferred T cells
BG Till, OW Press
Expert Opinion on Biological Therapy 2009
Immunobiology of human cytomegalovirus: from bench to bedside
T Crough, R Khanna
Clinical microbiology reviews 2009
Central Memory CD8 + T Cells Induce Graft-versus-Host Disease and Mediate Graft-versus-Leukemia
H Zheng, C Matte-Martone, D Jain, J McNiff, WD Shlomchik
Journal of immunology (Baltimore, Md. : 1950) 2009
Fifteen Years of Gene Therapy Based on Chimeric Antigen Receptors: “Are We Nearly There Yet?”
G Dotti, B Savoldo, M Brenner
Human Gene Therapy 2009
Adoptive T-cell therapy for B-cell malignancies
M Hudecek, LD Anderson, T Nishida, SR Riddell
Expert Review of Hematology 2009
Safety and immunologic effects of IL-15 administration in nonhuman primates
C Berger, M Berger, RC Hackman, M Gough, C Elliott, MC Jensen, SR Riddell
Blood 2009
T Cell Receptor Gene Therapy for Cancer
TM Schmitt, GB Ragnarsson, PD Greenberg
Human Gene Therapy 2009
Adoptively transferred effector cells derived from naive rather than central memory CD8+ T cells mediate superior antitumor immunity
CS Hinrichs, ZA Borman, L Cassard, L Gattinoni, R Spolski, Z Yu, L Sanchez-Perez, P Muranski, SJ Kern, C Logun, DC Palmer, Y Ji, RN Reger, WJ Leonard, RL Danner, SA Rosenberg, NP Restifo
Proceedings of the National Academy of Sciences 2009
Depletion of CD4 T cells enhances immunotherapy for neuroblastoma after syngeneic HSCT but compromises development of antitumor immune memory
W Jing, JA Gershan, BD Johnson
Blood 2009
Distribution, Persistence, and Efficacy of Adoptively Transferred Central and Effector Memory-Derived Autologous Simian Immunodeficiency Virus-Specific CD8 + T Cell Clones in Rhesus Macaques during Acute Infection
JT Minang, MT Trivett, DL Bolton, CM Trubey, JD Estes, Y Li, J Smedley, R Pung, M Rosati, R Jalah, GN Pavlakis, BK Felber, M Piatak, M Roederer, JD Lifson, DE Ott, C Ohlen
Journal of immunology (Baltimore, Md. : 1950) 2009
Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients
HE Heslop, KS Slobod, MA Pule, GA Hale, A Rousseau, CA Smith, CM Bollard, H Liu, MF Wu, RJ Rochester, PJ Amrolia, JL Hurwitz, MK Brenner, CM Rooney
Blood 2009
Adoptive transfer of virus-specific and tumor-specific T cell immunity
C Berger, CJ Turtle, MC Jensen, SR Riddell
Current Opinion in Immunology 2009
Highlights of the First International “Immunotherapy in Pediatric Oncology: Progress and Challenges” Meeting
CM Capitini, LJ Cooper, RM Egeler, R Handgretinger, F Locatelli, PM Sondel, CL Mackall
Journal of Pediatric Hematology/Oncology 2009
Functionally Distinct LAG-3 and PD-1 Subsets on Activated and Chronically Stimulated CD8 T Cells
JF Grosso, MV Goldberg, D Getnet, TC Bruno, HR Yen, KJ Pyle, E Hipkiss, DA Vignali, DM Pardoll, CG Drake
Journal of immunology (Baltimore, Md. : 1950) 2009
Cytotoxic T lymphocyte therapy with donor T cells prevents and treats adenovirus and Epstein-Barr virus infections after haploidentical and matched unrelated stem cell transplantation
AM Leen, A Christin, GD Myers, H Liu, CR Cruz, PJ Hanley, AA Kennedy-Nasser, KS Leung, AP Gee, RA Krance, MK Brenner, HE Heslop, CM Rooney, CM Bollard
Blood 2009
Lymphoma immunotherapy: vaccines, adoptive cell transfer and immunotransplant
J Brody, R Levy
Immunotherapy 2009
Manufacturing Validation of Biologically Functional T Cells Targeted to CD19 Antigen for Autologous Adoptive Cell Therapy
D Hollyman, J Stefanski, M Przybylowski, S Bartido, O Borquez-Ojeda, C Taylor, R Yeh, V Capacio, M Olszewska, J Hosey, M Sadelain, RJ Brentjens, I Rivière
Journal of Immunotherapy 2009
Nucleofection of DCs to Generate Multivirus-specific T Cells for Prevention or Treatment of Viral Infections in the Immunocompromised Host
U Gerdemann, AS Christin, JF Vera, CA Ramos, Y Fujita, H Liu, D Dilloo, HE Heslop, MK Brenner, CM Rooney, AM Leen
Molecular Therapy 2009
Adoptive T cell therapy of cancer
TN Schumacher, NP Restifo
Current Opinion in Immunology 2009
Engineering lymphocyte subsets: tools, trials and tribulations
CH June, BR Blazar, JL Riley
Nature reviews. Immunology 2009
The promise and potential pitfalls of chimeric antigen receptors
M Sadelain, R Brentjens, I Rivière
Current Opinion in Immunology 2009
Trafficking, Persistence, and Activation State of Adoptively Transferred Allogeneic and Autologous Simian Immunodeficiency Virus-Specific CD8 + T Cell Clones during Acute and Chronic Infection of Rhesus Macaques
DL Bolton, JT Minang, MT Trivett, K Song, JJ Tuscher, Y Li, M Piatak, D OConnor, JD Lifson, M Roederer, C Ohlen
Journal of immunology (Baltimore, Md. : 1950) 2009
Immunotherapy of Human Cancers Using Gene Modified T Lymphocytes
Vera JF, Brenner MK, Dotti G
Current gene therapy 2009
Advances in cellular therapy: 5th International Symposium on the clinical use of cellular products, 19 and 20 March 2009, Nürnberg, Germany
Ullrich E, Bosch J, Aigner M, Völkl S, Dudziak D, Spriewald B, Schuler G, Andreesen R, Mackensen A
Cancer Immunology, Immunotherapy 2009
TCR transgenes and transgene cassettes for TCR gene therapy: status in 2008
Uckert W, Schumacher TN
Cancer Immunology, Immunotherapy 2009
Adoptive immunotherapy for indolent non-Hodgkin lymphoma and mantle cell lymphoma using genetically modified autologous CD20-specific T cells
BG Till, MC Jensen, J Wang, EY Chen, BL Wood, HA Greisman, X Qian, SE James, A Raubitschek, SJ Forman, AK Gopal, JM Pagel, CG Lindgren, PD Greenberg, SR Riddell, OW Press
Blood 2008
Redirecting specificity of T-cell populations for CD19 using the Sleeping Beauty system
H Singh, PR Manuri, S Olivares, N Dara, MJ Dawson, H Huls, PB Hackett, DB Kohn, EJ Shpall, RE Champlin, LJ Cooper
Cancer research 2008
Post-transplant adoptive T-cell immunotherapy
NA Aqui, CH June
Best practice & research. Clinical haematology 2008
Characterizing and optimizing immune responses to leukaemia antigens after allogeneic stem cell transplantation
K Rezvani, CS Lecturer, AJ Barrett
Best practice & research. Clinical haematology 2008
Adoptive immunotherapy: good habits instilled at youth have long-term benefits
CM Paulos, MM Suhoski, G Plesa, T Jiang, S Basu, TN Golovina, S Jiang, NA Aqui, DJ Powell, BL Levine, RG Carroll, JL Riley, CH June
Immunologic Research 2008
Cancer treatment: the combination of vaccination with other therapies
MH Andersen, RB Sørensen, D Schrama, IM Svane, JC Becker, PT Straten
Cancer Immunology, Immunotherapy 2008
Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma
MA Pule, B Savoldo, GD Myers, C Rossig, HV Russell, G Dotti, MH Huls, E Liu, AP Gee, Z Mei, E Yvon, HL Weiss, H Liu, CM Rooney, HE Heslop, MK Brenner
Nature Medicine 2008
A heterologous DNA prime/protein boost immunization strategy for rhesus cytomegalovirus
K Abel, L Strelow, Y Yue, MK Eberhardt, KA Schmidt, PA Barry
Vaccine 2008
Immunotherapy targeting EBV-expressing lymphoproliferative diseases
CM Bollard, LJ Cooper, HE Heslop
Best practice & research. Clinical haematology 2008
Allogeneic lymphocytes persist and traffic in feral MHC-matched mauritian cynomolgus macaques
JM Greene, BJ Burwitz, AJ Blasky, TL Mattila, JJ Hong, EG Rakasz, RW Wiseman, KJ Hasenkrug, PJ Skinner, SL O'Connor, DH O'Connor
PloS one 2008

← Previous 1 2 3 … 19 20 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Blogged by 4
Posted by 1 X users
Referenced in 83 patents
Highlighted by 1 platforms
459 readers on Mendeley
See more details